D56.1
|
Beta thalassemia
|
D57.02
|
Hb-SS disease with splenic sequestration
|
D57.1
|
Sickle-cell disease without crisis
|
D57.212
|
Sickle-cell/Hb-C disease with splenic sequestration
|
D57.412
|
Sickle-cell thalassemia, unspecified, with splenic sequestration
|
D57.812
|
Other sickle-cell disorders with splenic sequestration
|
D68.8
|
Other specified coagulation defects
|
D73.1
|
Hypersplenism
|
D73.2
|
Chronic congestive splenomegaly
|
D73.81
|
Neutropenic splenomegaly
|
D73.89
|
Other diseases of spleen
|
E03.5
|
Myxedema coma
|
E08.00
|
Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)
|
E08.01
|
Diabetes mellitus due to underlying condition with hyperosmolarity with coma
|
E08.10
|
Diabetes mellitus due to underlying condition with ketoacidosis without coma
|
E08.11
|
Diabetes mellitus due to underlying condition with ketoacidosis with coma
|
E08.21
|
Diabetes mellitus due to underlying condition with diabetic nephropathy
|
E08.22
|
Diabetes mellitus due to underlying condition with diabetic chronic kidney disease
|
E08.29
|
Diabetes mellitus due to underlying condition with other diabetic kidney complication
|
E08.3211
|
Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy with macular edema, right eye
|
E08.3212
|
Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy with macular edema, left eye
|
E08.3213
|
Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy with macular edema, bilateral
|
E08.3291
|
Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy without macular edema, right eye
|
E08.3292
|
Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy without macular edema, left eye
|
E08.3293
|
Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy without macular edema, bilateral
|
E08.3311
|
Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy with macular edema, right eye
|
E08.3312
|
Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy with macular edema, left eye
|
E08.3313
|
Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy with macular edema, bilateral
|
E08.3391
|
Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy without macular edema, right eye
|
E08.3392
|
Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy without macular edema, left eye
|
E08.3393
|
Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy without macular edema, bilateral
|
E08.3411
|
Diabetes mellitus due to underlying condition with severe nonproliferative diabetic retinopathy with macular edema, right eye
|
E08.3412
|
Diabetes mellitus due to underlying condition with severe nonproliferative diabetic retinopathy with macular edema, left eye
|
E08.3413
|
Diabetes mellitus due to underlying condition with severe nonproliferative diabetic retinopathy with macular edema, bilateral
|
E08.3491
|
Diabetes mellitus due to underlying condition with severe nonproliferative diabetic retinopathy without macular edema, right eye
|
E08.3492
|
Diabetes mellitus due to underlying condition with severe nonproliferative diabetic retinopathy without macular edema, left eye
|
E08.3493
|
Diabetes mellitus due to underlying condition with severe nonproliferative diabetic retinopathy without macular edema, bilateral
|
E08.3511
|
Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with macular edema, right eye
|
E08.3512
|
Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with macular edema, left eye
|
E08.3513
|
Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with macular edema, bilateral
|
E08.3591
|
Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy without macular edema, right eye
|
E08.3592
|
Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy without macular edema, left eye
|
E08.3593
|
Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy without macular edema, bilateral
|
E08.36
|
Diabetes mellitus due to underlying condition with diabetic cataract
|
E08.39
|
Diabetes mellitus due to underlying condition with other diabetic ophthalmic complication
|
E08.41
|
Diabetes mellitus due to underlying condition with diabetic mononeuropathy
|
E08.42
|
Diabetes mellitus due to underlying condition with diabetic polyneuropathy
|
E08.43
|
Diabetes mellitus due to underlying condition with diabetic autonomic (poly)neuropathy
|
E08.44
|
Diabetes mellitus due to underlying condition with diabetic amyotrophy
|
E08.49
|
Diabetes mellitus due to underlying condition with other diabetic neurological complication
|
E08.51
|
Diabetes mellitus due to underlying condition with diabetic peripheral angiopathy without gangrene
|
E08.52
|
Diabetes mellitus due to underlying condition with diabetic peripheral angiopathy with gangrene
|
E08.59
|
Diabetes mellitus due to underlying condition with other circulatory complications
|
E08.610
|
Diabetes mellitus due to underlying condition with diabetic neuropathic arthropathy
|
E08.618
|
Diabetes mellitus due to underlying condition with other diabetic arthropathy
|
E08.620
|
Diabetes mellitus due to underlying condition with diabetic dermatitis
|
E08.621
|
Diabetes mellitus due to underlying condition with foot ulcer
|
E08.622
|
Diabetes mellitus due to underlying condition with other skin ulcer
|
E08.628
|
Diabetes mellitus due to underlying condition with other skin complications
|
E08.630
|
Diabetes mellitus due to underlying condition with periodontal disease
|
E08.638
|
Diabetes mellitus due to underlying condition with other oral complications
|
E08.641
|
Diabetes mellitus due to underlying condition with hypoglycemia with coma
|
E08.649
|
Diabetes mellitus due to underlying condition with hypoglycemia without coma
|
E08.65
|
Diabetes mellitus due to underlying condition with hyperglycemia
|
E08.69
|
Diabetes mellitus due to underlying condition with other specified complication
|
E08.9
|
Diabetes mellitus due to underlying condition without complications
|
E09.00
|
Drug or chemical induced diabetes mellitus with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)
|
E09.01
|
Drug or chemical induced diabetes mellitus with hyperosmolarity with coma
|
E09.10
|
Drug or chemical induced diabetes mellitus with ketoacidosis without coma
|
E09.11
|
Drug or chemical induced diabetes mellitus with ketoacidosis with coma
|
E09.21
|
Drug or chemical induced diabetes mellitus with diabetic nephropathy
|
E09.22
|
Drug or chemical induced diabetes mellitus with diabetic chronic kidney disease
|
E09.29
|
Drug or chemical induced diabetes mellitus with other diabetic kidney complication
|
E09.3211
|
Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, right eye
|
E09.3212
|
Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, left eye
|
E09.3213
|
Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, bilateral
|
E09.3291
|
Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, right eye
|
E09.3292
|
Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, left eye
|
E09.3293
|
Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, bilateral
|
E09.3311
|
Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, right eye
|
E09.3312
|
Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, left eye
|
E09.3313
|
Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, bilateral
|
E09.3391
|
Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, right eye
|
E09.3392
|
Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, left eye
|
E09.3393
|
Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral
|
E09.3411
|
Drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye
|
E09.3412
|
Drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, left eye
|
E09.3413
|
Drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, bilateral
|
E09.3491
|
Drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, right eye
|
E09.3492
|
Drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, left eye
|
E09.3493
|
Drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, bilateral
|
E09.3511
|
Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with macular edema, right eye
|
E09.3512
|
Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with macular edema, left eye
|
E09.3513
|
Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with macular edema, bilateral
|
E09.3591
|
Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy without macular edema, right eye
|
E09.3592
|
Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy without macular edema, left eye
|
E09.3593
|
Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral
|
E09.36
|
Drug or chemical induced diabetes mellitus with diabetic cataract
|
E09.39
|
Drug or chemical induced diabetes mellitus with other diabetic ophthalmic complication
|
E09.41
|
Drug or chemical induced diabetes mellitus with neurological complications with diabetic mononeuropathy
|
E09.42
|
Drug or chemical induced diabetes mellitus with neurological complications with diabetic polyneuropathy
|
E09.43
|
Drug or chemical induced diabetes mellitus with neurological complications with diabetic autonomic (poly)neuropathy
|
E09.44
|
Drug or chemical induced diabetes mellitus with neurological complications with diabetic amyotrophy
|
E09.49
|
Drug or chemical induced diabetes mellitus with neurological complications with other diabetic neurological complication
|
E09.51
|
Drug or chemical induced diabetes mellitus with diabetic peripheral angiopathy without gangrene
|
E09.52
|
Drug or chemical induced diabetes mellitus with diabetic peripheral angiopathy with gangrene
|
E09.59
|
Drug or chemical induced diabetes mellitus with other circulatory complications
|
E09.610
|
Drug or chemical induced diabetes mellitus with diabetic neuropathic arthropathy
|
E09.618
|
Drug or chemical induced diabetes mellitus with other diabetic arthropathy
|
E09.620
|
Drug or chemical induced diabetes mellitus with diabetic dermatitis
|
E09.621
|
Drug or chemical induced diabetes mellitus with foot ulcer
|
E09.622
|
Drug or chemical induced diabetes mellitus with other skin ulcer
|
E09.628
|
Drug or chemical induced diabetes mellitus with other skin complications
|
E09.630
|
Drug or chemical induced diabetes mellitus with periodontal disease
|
E09.638
|
Drug or chemical induced diabetes mellitus with other oral complications
|
E09.641
|
Drug or chemical induced diabetes mellitus with hypoglycemia with coma
|
E09.649
|
Drug or chemical induced diabetes mellitus with hypoglycemia without coma
|
E09.65
|
Drug or chemical induced diabetes mellitus with hyperglycemia
|
E09.69
|
Drug or chemical induced diabetes mellitus with other specified complication
|
E09.9
|
Drug or chemical induced diabetes mellitus without complications
|
E10.10
|
Type 1 diabetes mellitus with ketoacidosis without coma
|
E10.11
|
Type 1 diabetes mellitus with ketoacidosis with coma
|
E10.21
|
Type 1 diabetes mellitus with diabetic nephropathy
|
E10.22
|
Type 1 diabetes mellitus with diabetic chronic kidney disease
|
E10.29
|
Type 1 diabetes mellitus with other diabetic kidney complication
|
E10.3211
|
Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, right eye
|
E10.3212
|
Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, left eye
|
E10.3213
|
Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, bilateral
|
E10.3291
|
Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, right eye
|
E10.3292
|
Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, left eye
|
E10.3293
|
Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, bilateral
|
E10.3311
|
Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, right eye
|
E10.3312
|
Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, left eye
|
E10.3313
|
Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, bilateral
|
E10.3391
|
Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, right eye
|
E10.3392
|
Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, left eye
|
E10.3393
|
Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral
|
E10.3411
|
Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye
|
E10.3412
|
Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, left eye
|
E10.3413
|
Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, bilateral
|
E10.3491
|
Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, right eye
|
E10.3492
|
Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, left eye
|
E10.3493
|
Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, bilateral
|
E10.3511
|
Type 1 diabetes mellitus with proliferative diabetic retinopathy with macular edema, right eye
|
E10.3512
|
Type 1 diabetes mellitus with proliferative diabetic retinopathy with macular edema, left eye
|
E10.3513
|
Type 1 diabetes mellitus with proliferative diabetic retinopathy with macular edema, bilateral
|
E10.3591
|
Type 1 diabetes mellitus with proliferative diabetic retinopathy without macular edema, right eye
|
E10.3592
|
Type 1 diabetes mellitus with proliferative diabetic retinopathy without macular edema, left eye
|
E10.3593
|
Type 1 diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral
|
E10.36
|
Type 1 diabetes mellitus with diabetic cataract
|
E10.39
|
Type 1 diabetes mellitus with other diabetic ophthalmic complication
|
E10.41
|
Type 1 diabetes mellitus with diabetic mononeuropathy
|
E10.42
|
Type 1 diabetes mellitus with diabetic polyneuropathy
|
E10.43
|
Type 1 diabetes mellitus with diabetic autonomic (poly)neuropathy
|
E10.44
|
Type 1 diabetes mellitus with diabetic amyotrophy
|
E10.49
|
Type 1 diabetes mellitus with other diabetic neurological complication
|
E10.51
|
Type 1 diabetes mellitus with diabetic peripheral angiopathy without gangrene
|
E10.52
|
Type 1 diabetes mellitus with diabetic peripheral angiopathy with gangrene
|
E10.59
|
Type 1 diabetes mellitus with other circulatory complications
|
E10.610
|
Type 1 diabetes mellitus with diabetic neuropathic arthropathy
|
E10.618
|
Type 1 diabetes mellitus with other diabetic arthropathy
|
E10.620
|
Type 1 diabetes mellitus with diabetic dermatitis
|
E10.621
|
Type 1 diabetes mellitus with foot ulcer
|
E10.622
|
Type 1 diabetes mellitus with other skin ulcer
|
E10.628
|
Type 1 diabetes mellitus with other skin complications
|
E10.630
|
Type 1 diabetes mellitus with periodontal disease
|
E10.638
|
Type 1 diabetes mellitus with other oral complications
|
E10.641
|
Type 1 diabetes mellitus with hypoglycemia with coma
|
E10.649
|
Type 1 diabetes mellitus with hypoglycemia without coma
|
E10.65
|
Type 1 diabetes mellitus with hyperglycemia
|
E10.69
|
Type 1 diabetes mellitus with other specified complication
|
E10.9
|
Type 1 diabetes mellitus without complications
|
E11.00
|
Type 2 diabetes mellitus with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)
|
E11.01
|
Type 2 diabetes mellitus with hyperosmolarity with coma
|
E11.21
|
Type 2 diabetes mellitus with diabetic nephropathy
|
E11.22
|
Type 2 diabetes mellitus with diabetic chronic kidney disease
|
E11.29
|
Type 2 diabetes mellitus with other diabetic kidney complication
|
E11.3211
|
Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, right eye
|
E11.3212
|
Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, left eye
|
E11.3213
|
Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, bilateral
|
E11.3291
|
Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, right eye
|
E11.3292
|
Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, left eye
|
E11.3293
|
Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, bilateral
|
E11.3311
|
Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, right eye
|
E11.3312
|
Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, left eye
|
E11.3313
|
Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, bilateral
|
E11.3391
|
Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, right eye
|
E11.3392
|
Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, left eye
|
E11.3393
|
Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral
|
E11.3411
|
Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye
|
E11.3412
|
Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, left eye
|
E11.3413
|
Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, bilateral
|
E11.3491
|
Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, right eye
|
E11.3492
|
Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, left eye
|
E11.3493
|
Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, bilateral
|
E11.3511
|
Type 2 diabetes mellitus with proliferative diabetic retinopathy with macular edema, right eye
|
E11.3512
|
Type 2 diabetes mellitus with proliferative diabetic retinopathy with macular edema, left eye
|
E11.3513
|
Type 2 diabetes mellitus with proliferative diabetic retinopathy with macular edema, bilateral
|
E11.3591
|
Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, right eye
|
E11.3592
|
Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, left eye
|
E11.3593
|
Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral
|
E11.36
|
Type 2 diabetes mellitus with diabetic cataract
|
E11.39
|
Type 2 diabetes mellitus with other diabetic ophthalmic complication
|
E11.41
|
Type 2 diabetes mellitus with diabetic mononeuropathy
|
E11.42
|
Type 2 diabetes mellitus with diabetic polyneuropathy
|
E11.43
|
Type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy
|
E11.44
|
Type 2 diabetes mellitus with diabetic amyotrophy
|
E11.49
|
Type 2 diabetes mellitus with other diabetic neurological complication
|
E11.51
|
Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene
|
E11.52
|
Type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene
|
E11.59
|
Type 2 diabetes mellitus with other circulatory complications
|
E11.610
|
Type 2 diabetes mellitus with diabetic neuropathic arthropathy
|
E11.618
|
Type 2 diabetes mellitus with other diabetic arthropathy
|
E11.620
|
Type 2 diabetes mellitus with diabetic dermatitis
|
E11.621
|
Type 2 diabetes mellitus with foot ulcer
|
E11.622
|
Type 2 diabetes mellitus with other skin ulcer
|
E11.628
|
Type 2 diabetes mellitus with other skin complications
|
E11.630
|
Type 2 diabetes mellitus with periodontal disease
|
E11.638
|
Type 2 diabetes mellitus with other oral complications
|
E11.641
|
Type 2 diabetes mellitus with hypoglycemia with coma
|
E11.649
|
Type 2 diabetes mellitus with hypoglycemia without coma
|
E11.65
|
Type 2 diabetes mellitus with hyperglycemia
|
E11.69
|
Type 2 diabetes mellitus with other specified complication
|
E11.9
|
Type 2 diabetes mellitus without complications
|
E13.00
|
Other specified diabetes mellitus with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)
|
E13.01
|
Other specified diabetes mellitus with hyperosmolarity with coma
|
E13.10
|
Other specified diabetes mellitus with ketoacidosis without coma
|
E13.11
|
Other specified diabetes mellitus with ketoacidosis with coma
|
E13.21
|
Other specified diabetes mellitus with diabetic nephropathy
|
E13.22
|
Other specified diabetes mellitus with diabetic chronic kidney disease
|
E13.29
|
Other specified diabetes mellitus with other diabetic kidney complication
|
E13.3211
|
Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, right eye
|
E13.3212
|
Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, left eye
|
E13.3213
|
Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, bilateral
|
E13.3291
|
Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, right eye
|
E13.3292
|
Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, left eye
|
E13.3293
|
Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, bilateral
|
E13.3311
|
Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, right eye
|
E13.3312
|
Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, left eye
|
E13.3313
|
Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, bilateral
|
E13.3391
|
Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, right eye
|
E13.3392
|
Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, left eye
|
E13.3393
|
Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral
|
E13.3411
|
Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye
|
E13.3412
|
Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, left eye
|
E13.3413
|
Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, bilateral
|
E13.3491
|
Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, right eye
|
E13.3492
|
Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, left eye
|
E13.3493
|
Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, bilateral
|
E13.3511
|
Other specified diabetes mellitus with proliferative diabetic retinopathy with macular edema, right eye
|
E13.3512
|
Other specified diabetes mellitus with proliferative diabetic retinopathy with macular edema, left eye
|
E13.3513
|
Other specified diabetes mellitus with proliferative diabetic retinopathy with macular edema, bilateral
|
E13.3591
|
Other specified diabetes mellitus with proliferative diabetic retinopathy without macular edema, right eye
|
E13.3592
|
Other specified diabetes mellitus with proliferative diabetic retinopathy without macular edema, left eye
|
E13.3593
|
Other specified diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral
|
E13.36
|
Other specified diabetes mellitus with diabetic cataract
|
E13.39
|
Other specified diabetes mellitus with other diabetic ophthalmic complication
|
E13.41
|
Other specified diabetes mellitus with diabetic mononeuropathy
|
E13.42
|
Other specified diabetes mellitus with diabetic polyneuropathy
|
E13.43
|
Other specified diabetes mellitus with diabetic autonomic (poly)neuropathy
|
E13.44
|
Other specified diabetes mellitus with diabetic amyotrophy
|
E13.49
|
Other specified diabetes mellitus with other diabetic neurological complication
|
E13.51
|
Other specified diabetes mellitus with diabetic peripheral angiopathy without gangrene
|
E13.52
|
Other specified diabetes mellitus with diabetic peripheral angiopathy with gangrene
|
E13.59
|
Other specified diabetes mellitus with other circulatory complications
|
E13.610
|
Other specified diabetes mellitus with diabetic neuropathic arthropathy
|
E13.618
|
Other specified diabetes mellitus with other diabetic arthropathy
|
E13.620
|
Other specified diabetes mellitus with diabetic dermatitis
|
E13.621
|
Other specified diabetes mellitus with foot ulcer
|
E13.622
|
Other specified diabetes mellitus with other skin ulcer
|
E13.628
|
Other specified diabetes mellitus with other skin complications
|
E13.630
|
Other specified diabetes mellitus with periodontal disease
|
E13.638
|
Other specified diabetes mellitus with other oral complications
|
E13.641
|
Other specified diabetes mellitus with hypoglycemia with coma
|
E13.649
|
Other specified diabetes mellitus with hypoglycemia without coma
|
E13.65
|
Other specified diabetes mellitus with hyperglycemia
|
E13.69
|
Other specified diabetes mellitus with other specified complication
|
E13.9
|
Other specified diabetes mellitus without complications
|
E20.0
|
Idiopathic hypoparathyroidism
|
E20.1
|
Pseudohypoparathyroidism
|
E20.810
|
Autosomal dominant hypocalcemia
|
E20.811
|
Secondary hypoparathyroidism in diseases classified elsewhere
|
E20.812
|
Autoimmune hypoparathyroidism
|
E20.818
|
Other specified hypoparathyroidism due to impaired parathyroid hormone secretion
|
E20.819
|
Hypoparathyroidism due to impaired parathyroid hormone secretion, unspecified
|
E20.89
|
Other specified hypoparathyroidism
|
E21.0
|
Primary hyperparathyroidism
|
E21.1
|
Secondary hyperparathyroidism, not elsewhere classified
|
E21.2
|
Other hyperparathyroidism
|
E21.4
|
Other specified disorders of parathyroid gland
|
E26.01
|
Conn's syndrome
|
E26.02
|
Glucocorticoid-remediable aldosteronism
|
E26.09
|
Other primary hyperaldosteronism
|
E26.1
|
Secondary hyperaldosteronism
|
E26.81
|
Bartter's syndrome
|
E26.89
|
Other hyperaldosteronism
|
E34.2
|
Ectopic hormone secretion, not elsewhere classified
|
E40
|
Kwashiorkor
|
E41
|
Nutritional marasmus
|
E42
|
Marasmic kwashiorkor
|
E44.0
|
Moderate protein-calorie malnutrition
|
E64.0
|
Sequelae of protein-calorie malnutrition
|
E67.2
|
Megavitamin-B6 syndrome
|
E67.8
|
Other specified hyperalimentation
|
E68
|
Sequelae of hyperalimentation
|
E79.0
|
Hyperuricemia without signs of inflammatory arthritis and tophaceous disease
|
E83.31
|
Familial hypophosphatemia
|
E83.32
|
Hereditary vitamin D-dependent rickets (type 1) (type 2)
|
E83.39
|
Other disorders of phosphorus metabolism
|
E83.41
|
Hypermagnesemia
|
E83.42
|
Hypomagnesemia
|
E83.49
|
Other disorders of magnesium metabolism
|
E83.51
|
Hypocalcemia
|
E83.52
|
Hypercalcemia
|
E83.59
|
Other disorders of calcium metabolism
|
E83.81
|
Hungry bone syndrome
|
E86.0
|
Dehydration
|
E86.1
|
Hypovolemia
|
E87.0
|
Hyperosmolality and hypernatremia
|
E87.1
|
Hypo-osmolality and hyponatremia
|
E87.4
|
Mixed disorder of acid-base balance
|
E87.5
|
Hyperkalemia
|
E87.6
|
Hypokalemia
|
E87.8
|
Other disorders of electrolyte and fluid balance, not elsewhere classified
|
E89.2
|
Postprocedural hypoparathyroidism
|
F05
|
Delirium due to known physiological condition
|
F10.20
|
Alcohol dependence, uncomplicated
|
F10.21
|
Alcohol dependence, in remission
|
F10.220
|
Alcohol dependence with intoxication, uncomplicated
|
F28
|
Other psychotic disorder not due to a substance or known physiological condition
|
F42.2
|
Mixed obsessional thoughts and acts
|
F42.3
|
Hoarding disorder
|
F42.4
|
Excoriation (skin-picking) disorder
|
F42.8
|
Other obsessive-compulsive disorder
|
F42.9
|
Obsessive-compulsive disorder, unspecified
|
F50.010
|
Anorexia nervosa, restricting type, mild
|
F50.011
|
Anorexia nervosa, restricting type, moderate
|
F50.012
|
Anorexia nervosa, restricting type, severe
|
F50.013
|
Anorexia nervosa, restricting type, extreme
|
F50.014
|
Anorexia nervosa, restricting type, in remission
|
F50.019
|
Anorexia nervosa, restricting type, unspecified
|
F50.020
|
Anorexia nervosa, binge eating/purging type, mild
|
F50.021
|
Anorexia nervosa, binge eating/purging type, moderate
|
F50.022
|
Anorexia nervosa, binge eating/purging type, severe
|
F50.023
|
Anorexia nervosa, binge eating/purging type, extreme
|
F50.024
|
Anorexia nervosa, binge eating/purging type, in remission
|
F50.029
|
Anorexia nervosa, binge eating/purging type, unspecified
|
F50.20
|
Bulimia nervosa, unspecified
|
F50.21
|
Bulimia nervosa, mild
|
F50.22
|
Bulimia nervosa, moderate
|
F50.23
|
Bulimia nervosa, severe
|
F50.24
|
Bulimia nervosa, extreme
|
F50.25
|
Bulimia nervosa, in remission
|
F50.810
|
Binge eating disorder, mild
|
F50.811
|
Binge eating disorder, moderate
|
F50.812
|
Binge eating disorder, severe
|
F50.813
|
Binge eating disorder, extreme
|
F50.814
|
Binge eating disorder, in remission
|
F50.819
|
Binge eating disorder, unspecified
|
F50.83
|
Pica in adults
|
F50.84
|
Rumination disorder in adults
|
F50.89
|
Other specified eating disorder
|
F95.1
|
Chronic motor or vocal tic disorder
|
F95.8
|
Other tic disorders
|
G25.3
|
Myoclonus
|
G25.61
|
Drug induced tics
|
G25.69
|
Other tics of organic origin
|
G40.401
|
Other generalized epilepsy and epileptic syndromes, not intractable, with status epilepticus
|
G40.409
|
Other generalized epilepsy and epileptic syndromes, not intractable, without status epilepticus
|
G40.411
|
Other generalized epilepsy and epileptic syndromes, intractable, with status epilepticus
|
G40.419
|
Other generalized epilepsy and epileptic syndromes, intractable, without status epilepticus
|
G71.3
|
Mitochondrial myopathy, not elsewhere classified
|
G71.8
|
Other primary disorders of muscles
|
G72.81
|
Critical illness myopathy
|
G72.89
|
Other specified myopathies
|
G73.7
|
Myopathy in diseases classified elsewhere
|
G95.11
|
Acute infarction of spinal cord (embolic) (nonembolic)
|
G95.19
|
Other vascular myelopathies
|
I10
|
Essential (primary) hypertension
|
I11.0
|
Hypertensive heart disease with heart failure
|
I11.9
|
Hypertensive heart disease without heart failure
|
I12.0
|
Hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease
|
I12.9
|
Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease
|
I13.0
|
Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease
|
I13.10
|
Hypertensive heart and chronic kidney disease without heart failure, with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease
|
I13.11
|
Hypertensive heart and chronic kidney disease without heart failure, with stage 5 chronic kidney disease, or end stage renal disease
|
I13.2
|
Hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease
|
I15.0
|
Renovascular hypertension
|
I15.1
|
Hypertension secondary to other renal disorders
|
I15.2
|
Hypertension secondary to endocrine disorders
|
I15.8
|
Other secondary hypertension
|
I21.01
|
ST elevation (STEMI) myocardial infarction involving left main coronary artery
|
I21.02
|
ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery
|
I21.09
|
ST elevation (STEMI) myocardial infarction involving other coronary artery of anterior wall
|
I21.11
|
ST elevation (STEMI) myocardial infarction involving right coronary artery
|
I21.19
|
ST elevation (STEMI) myocardial infarction involving other coronary artery of inferior wall
|
I21.21
|
ST elevation (STEMI) myocardial infarction involving left circumflex coronary artery
|
I21.29
|
ST elevation (STEMI) myocardial infarction involving other sites
|
I21.4
|
Non-ST elevation (NSTEMI) myocardial infarction
|
I22.0
|
Subsequent ST elevation (STEMI) myocardial infarction of anterior wall
|
I22.1
|
Subsequent ST elevation (STEMI) myocardial infarction of inferior wall
|
I22.2
|
Subsequent non-ST elevation (NSTEMI) myocardial infarction
|
I22.8
|
Subsequent ST elevation (STEMI) myocardial infarction of other sites
|
I23.0
|
Hemopericardium as current complication following acute myocardial infarction
|
I23.3
|
Rupture of cardiac wall without hemopericardium as current complication following acute myocardial infarction
|
I23.6
|
Thrombosis of atrium, auricular appendage, and ventricle as current complications following acute myocardial infarction
|
I23.7
|
Postinfarction angina
|
I23.8
|
Other current complications following acute myocardial infarction
|
I24.0
|
Acute coronary thrombosis not resulting in myocardial infarction
|
I25.5
|
Ischemic cardiomyopathy
|
I25.6
|
Silent myocardial ischemia
|
I25.89
|
Other forms of chronic ischemic heart disease
|
I26.03
|
Cement embolism of pulmonary artery with acute cor pulmonale
|
I26.04
|
Fat embolism of pulmonary artery with acute cor pulmonale
|
I26.09
|
Other pulmonary embolism with acute cor pulmonale
|
I26.93
|
Single subsegmental thrombotic pulmonary embolism without acute cor pulmonale
|
I26.94
|
Multiple subsegmental thrombotic pulmonary emboli without acute cor pulmonale
|
I26.95
|
Cement embolism of pulmonary artery without acute cor pulmonale
|
I26.96
|
Fat embolism of pulmonary artery without acute cor pulmonale
|
I26.99
|
Other pulmonary embolism without acute cor pulmonale
|
I42.0
|
Dilated cardiomyopathy
|
I42.5
|
Other restrictive cardiomyopathy
|
I42.8
|
Other cardiomyopathies
|
I45.81
|
Long QT syndrome
|
I46.2
|
Cardiac arrest due to underlying cardiac condition
|
I46.8
|
Cardiac arrest due to other underlying condition
|
I47.0
|
Re-entry ventricular arrhythmia
|
I47.10
|
Supraventricular tachycardia, unspecified
|
I47.11
|
Inappropriate sinus tachycardia, so stated
|
I47.21
|
Torsades de pointes
|
I48.0
|
Paroxysmal atrial fibrillation
|
I48.11
|
Longstanding persistent atrial fibrillation
|
I48.19
|
Other persistent atrial fibrillation
|
I48.20
|
Chronic atrial fibrillation, unspecified
|
I48.21
|
Permanent atrial fibrillation
|
I48.3
|
Typical atrial flutter
|
I48.4
|
Atypical atrial flutter
|
I49.01
|
Ventricular fibrillation
|
I49.02
|
Ventricular flutter
|
I49.1
|
Atrial premature depolarization
|
I49.2
|
Junctional premature depolarization
|
I49.3
|
Ventricular premature depolarization
|
I49.49
|
Other premature depolarization
|
I49.5
|
Sick sinus syndrome
|
I49.8
|
Other specified cardiac arrhythmias
|
I50.21
|
Acute systolic (congestive) heart failure
|
I50.22
|
Chronic systolic (congestive) heart failure
|
I50.23
|
Acute on chronic systolic (congestive) heart failure
|
I50.31
|
Acute diastolic (congestive) heart failure
|
I50.32
|
Chronic diastolic (congestive) heart failure
|
I50.33
|
Acute on chronic diastolic (congestive) heart failure
|
I50.41
|
Acute combined systolic (congestive) and diastolic (congestive) heart failure
|
I50.42
|
Chronic combined systolic (congestive) and diastolic (congestive) heart failure
|
I50.43
|
Acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure
|
I51.3
|
Intracardiac thrombosis, not elsewhere classified
|
I51.81
|
Takotsubo syndrome
|
I51.89
|
Other ill-defined heart diseases
|
I95.0
|
Idiopathic hypotension
|
I95.1
|
Orthostatic hypotension
|
I95.2
|
Hypotension due to drugs
|
I95.3
|
Hypotension of hemodialysis
|
I95.81
|
Postprocedural hypotension
|
I95.89
|
Other hypotension
|
I97.110
|
Postprocedural cardiac insufficiency following cardiac surgery
|
I97.111
|
Postprocedural cardiac insufficiency following other surgery
|
I97.120
|
Postprocedural cardiac arrest following cardiac surgery
|
I97.121
|
Postprocedural cardiac arrest following other surgery
|
I97.130
|
Postprocedural heart failure following cardiac surgery
|
I97.131
|
Postprocedural heart failure following other surgery
|
I97.190
|
Other postprocedural cardiac functional disturbances following cardiac surgery
|
I97.191
|
Other postprocedural cardiac functional disturbances following other surgery
|
I97.89
|
Other postprocedural complications and disorders of the circulatory system, not elsewhere classified
|
K50.013
|
Crohn's disease of small intestine with fistula
|
K50.113
|
Crohn's disease of large intestine with fistula
|
K50.813
|
Crohn's disease of both small and large intestine with fistula
|
K51.013
|
Ulcerative (chronic) pancolitis with fistula
|
K51.213
|
Ulcerative (chronic) proctitis with fistula
|
K51.313
|
Ulcerative (chronic) rectosigmoiditis with fistula
|
K51.413
|
Inflammatory polyps of colon with fistula
|
K51.513
|
Left sided colitis with fistula
|
K51.813
|
Other ulcerative colitis with fistula
|
K52.21
|
Food protein-induced enterocolitis syndrome
|
K52.22
|
Food protein-induced enteropathy
|
K52.29
|
Other allergic and dietetic gastroenteritis and colitis
|
K52.81
|
Eosinophilic gastritis or gastroenteritis
|
K52.831
|
Collagenous colitis
|
K52.832
|
Lymphocytic colitis
|
K52.838
|
Other microscopic colitis
|
K52.89
|
Other specified noninfective gastroenteritis and colitis
|
K56.50
|
Intestinal adhesions [bands], unspecified as to partial versus complete obstruction
|
K56.51
|
Intestinal adhesions [bands], with partial obstruction
|
K56.52
|
Intestinal adhesions [bands] with complete obstruction
|
K63.2
|
Fistula of intestine
|
K90.0
|
Celiac disease
|
K90.2
|
Blind loop syndrome, not elsewhere classified
|
K90.41
|
Non-celiac gluten sensitivity
|
K90.49
|
Malabsorption due to intolerance, not elsewhere classified
|
K90.89
|
Other intestinal malabsorption
|
K91.2
|
Postsurgical malabsorption, not elsewhere classified
|
M32.14
|
Glomerular disease in systemic lupus erythematosus
|
M32.15
|
Tubulo-interstitial nephropathy in systemic lupus erythematosus
|
M35.04
|
Sjogren syndrome with tubulo-interstitial nephropathy
|
M35.05
|
Sjogren syndrome with inflammatory arthritis
|
M35.06
|
Sjogren syndrome with peripheral nervous system involvement
|
M35.07
|
Sjogren syndrome with central nervous system involvement
|
M35.08
|
Sjogren syndrome with gastrointestinal involvement
|
M35.0A
|
Sjogren syndrome with glomerular disease
|
M35.0B
|
Sjogren syndrome with vasculitis
|
M35.0C
|
Sjogren syndrome with dental involvement
|
M63.811
|
Disorders of muscle in diseases classified elsewhere, right shoulder
|
M63.812
|
Disorders of muscle in diseases classified elsewhere, left shoulder
|
M63.821
|
Disorders of muscle in diseases classified elsewhere, right upper arm
|
M63.822
|
Disorders of muscle in diseases classified elsewhere, left upper arm
|
M63.831
|
Disorders of muscle in diseases classified elsewhere, right forearm
|
M63.832
|
Disorders of muscle in diseases classified elsewhere, left forearm
|
M63.841
|
Disorders of muscle in diseases classified elsewhere, right hand
|
M63.842
|
Disorders of muscle in diseases classified elsewhere, left hand
|
M63.851
|
Disorders of muscle in diseases classified elsewhere, right thigh
|
M63.852
|
Disorders of muscle in diseases classified elsewhere, left thigh
|
M63.861
|
Disorders of muscle in diseases classified elsewhere, right lower leg
|
M63.862
|
Disorders of muscle in diseases classified elsewhere, left lower leg
|
M63.871
|
Disorders of muscle in diseases classified elsewhere, right ankle and foot
|
M63.872
|
Disorders of muscle in diseases classified elsewhere, left ankle and foot
|
M63.88
|
Disorders of muscle in diseases classified elsewhere, other site
|
M63.89
|
Disorders of muscle in diseases classified elsewhere, multiple sites
|
N00.0
|
Acute nephritic syndrome with minor glomerular abnormality
|
N00.1
|
Acute nephritic syndrome with focal and segmental glomerular lesions
|
N00.2
|
Acute nephritic syndrome with diffuse membranous glomerulonephritis
|
N00.3
|
Acute nephritic syndrome with diffuse mesangial proliferative glomerulonephritis
|
N00.4
|
Acute nephritic syndrome with diffuse endocapillary proliferative glomerulonephritis
|
N00.5
|
Acute nephritic syndrome with diffuse mesangiocapillary glomerulonephritis
|
N00.6
|
Acute nephritic syndrome with dense deposit disease
|
N00.7
|
Acute nephritic syndrome with diffuse crescentic glomerulonephritis
|
N00.8
|
Acute nephritic syndrome with other morphologic changes
|
N01.0
|
Rapidly progressive nephritic syndrome with minor glomerular abnormality
|
N01.1
|
Rapidly progressive nephritic syndrome with focal and segmental glomerular lesions
|
N01.2
|
Rapidly progressive nephritic syndrome with diffuse membranous glomerulonephritis
|
N01.3
|
Rapidly progressive nephritic syndrome with diffuse mesangial proliferative glomerulonephritis
|
N01.4
|
Rapidly progressive nephritic syndrome with diffuse endocapillary proliferative glomerulonephritis
|
N01.5
|
Rapidly progressive nephritic syndrome with diffuse mesangiocapillary glomerulonephritis
|
N01.6
|
Rapidly progressive nephritic syndrome with dense deposit disease
|
N01.7
|
Rapidly progressive nephritic syndrome with diffuse crescentic glomerulonephritis
|
N01.8
|
Rapidly progressive nephritic syndrome with other morphologic changes
|
N02.0
|
Recurrent and persistent hematuria with minor glomerular abnormality
|
N02.1
|
Recurrent and persistent hematuria with focal and segmental glomerular lesions
|
N02.2
|
Recurrent and persistent hematuria with diffuse membranous glomerulonephritis
|
N02.3
|
Recurrent and persistent hematuria with diffuse mesangial proliferative glomerulonephritis
|
N02.4
|
Recurrent and persistent hematuria with diffuse endocapillary proliferative glomerulonephritis
|
N02.5
|
Recurrent and persistent hematuria with diffuse mesangiocapillary glomerulonephritis
|
N02.6
|
Recurrent and persistent hematuria with dense deposit disease
|
N02.7
|
Recurrent and persistent hematuria with diffuse crescentic glomerulonephritis
|
N02.8
|
Recurrent and persistent hematuria with other morphologic changes
|
N03.0
|
Chronic nephritic syndrome with minor glomerular abnormality
|
N03.1
|
Chronic nephritic syndrome with focal and segmental glomerular lesions
|
N03.2
|
Chronic nephritic syndrome with diffuse membranous glomerulonephritis
|
N03.3
|
Chronic nephritic syndrome with diffuse mesangial proliferative glomerulonephritis
|
N03.4
|
Chronic nephritic syndrome with diffuse endocapillary proliferative glomerulonephritis
|
N03.5
|
Chronic nephritic syndrome with diffuse mesangiocapillary glomerulonephritis
|
N03.6
|
Chronic nephritic syndrome with dense deposit disease
|
N03.7
|
Chronic nephritic syndrome with diffuse crescentic glomerulonephritis
|
N03.8
|
Chronic nephritic syndrome with other morphologic changes
|
N04.0
|
Nephrotic syndrome with minor glomerular abnormality
|
N04.1
|
Nephrotic syndrome with focal and segmental glomerular lesions
|
N04.20
|
Nephrotic syndrome with diffuse membranous glomerulonephritis, unspecified
|
N04.21
|
Primary membranous nephropathy with nephrotic syndrome
|
N04.22
|
Secondary membranous nephropathy with nephrotic syndrome
|
N04.29
|
Other nephrotic syndrome with diffuse membranous glomerulonephritis
|
N04.3
|
Nephrotic syndrome with diffuse mesangial proliferative glomerulonephritis
|
N04.4
|
Nephrotic syndrome with diffuse endocapillary proliferative glomerulonephritis
|
N04.5
|
Nephrotic syndrome with diffuse mesangiocapillary glomerulonephritis
|
N04.6
|
Nephrotic syndrome with dense deposit disease
|
N04.7
|
Nephrotic syndrome with diffuse crescentic glomerulonephritis
|
N04.8
|
Nephrotic syndrome with other morphologic changes
|
N06.0
|
Isolated proteinuria with minor glomerular abnormality
|
N06.1
|
Isolated proteinuria with focal and segmental glomerular lesions
|
N06.20
|
Isolated proteinuria with diffuse membranous glomerulonephritis, unspecified
|
N06.21
|
Primary membranous nephropathy with isolated proteinuria
|
N06.22
|
Secondary membranous nephropathy with isolated proteinuria
|
N06.29
|
Other isolated proteinuria with diffuse membranous glomerulonephritis
|
N06.3
|
Isolated proteinuria with diffuse mesangial proliferative glomerulonephritis
|
N06.4
|
Isolated proteinuria with diffuse endocapillary proliferative glomerulonephritis
|
N06.5
|
Isolated proteinuria with diffuse mesangiocapillary glomerulonephritis
|
N06.6
|
Isolated proteinuria with dense deposit disease
|
N06.7
|
Isolated proteinuria with diffuse crescentic glomerulonephritis
|
N06.8
|
Isolated proteinuria with other morphologic lesion
|
N07.0
|
Hereditary nephropathy, not elsewhere classified with minor glomerular abnormality
|
N07.1
|
Hereditary nephropathy, not elsewhere classified with focal and segmental glomerular lesions
|
N07.2
|
Hereditary nephropathy, not elsewhere classified with diffuse membranous glomerulonephritis
|
N07.3
|
Hereditary nephropathy, not elsewhere classified with diffuse mesangial proliferative glomerulonephritis
|
N07.4
|
Hereditary nephropathy, not elsewhere classified with diffuse endocapillary proliferative glomerulonephritis
|
N07.5
|
Hereditary nephropathy, not elsewhere classified with diffuse mesangiocapillary glomerulonephritis
|
N07.6
|
Hereditary nephropathy, not elsewhere classified with dense deposit disease
|
N07.7
|
Hereditary nephropathy, not elsewhere classified with diffuse crescentic glomerulonephritis
|
N07.8
|
Hereditary nephropathy, not elsewhere classified with other morphologic lesions
|
N08
|
Glomerular disorders in diseases classified elsewhere
|
N14.0
|
Analgesic nephropathy
|
N14.3
|
Nephropathy induced by heavy metals
|
N14.4
|
Toxic nephropathy, not elsewhere classified
|
N15.0
|
Balkan nephropathy
|
N15.8
|
Other specified renal tubulo-interstitial diseases
|
N16
|
Renal tubulo-interstitial disorders in diseases classified elsewhere
|
N17.0
|
Acute kidney failure with tubular necrosis
|
N17.1
|
Acute kidney failure with acute cortical necrosis
|
N17.2
|
Acute kidney failure with medullary necrosis
|
N17.8
|
Other acute kidney failure
|
N18.1
|
Chronic kidney disease, stage 1
|
N18.2
|
Chronic kidney disease, stage 2 (mild)
|
N18.31
|
Chronic kidney disease, stage 3a
|
N18.32
|
Chronic kidney disease, stage 3b
|
N18.4
|
Chronic kidney disease, stage 4 (severe)
|
N18.5
|
Chronic kidney disease, stage 5
|
N18.6
|
End stage renal disease
|
N25.0
|
Renal osteodystrophy
|
N25.1
|
Nephrogenic diabetes insipidus
|
N25.81
|
Secondary hyperparathyroidism of renal origin
|
N25.89
|
Other disorders resulting from impaired renal tubular function
|
N26.1
|
Atrophy of kidney (terminal)
|
N26.2
|
Page kidney
|
N28.0
|
Ischemia and infarction of kidney
|
N29
|
Other disorders of kidney and ureter in diseases classified elsewhere
|
O02.1
|
Missed abortion
|
O03.1
|
Delayed or excessive hemorrhage following incomplete spontaneous abortion
|
O03.2
|
Embolism following incomplete spontaneous abortion
|
O03.31
|
Shock following incomplete spontaneous abortion
|
O03.32
|
Renal failure following incomplete spontaneous abortion
|
O03.33
|
Metabolic disorder following incomplete spontaneous abortion
|
O03.34
|
Damage to pelvic organs following incomplete spontaneous abortion
|
O03.35
|
Other venous complications following incomplete spontaneous abortion
|
O03.36
|
Cardiac arrest following incomplete spontaneous abortion
|
O03.38
|
Urinary tract infection following incomplete spontaneous abortion
|
O03.39
|
Incomplete spontaneous abortion with other complications
|
O03.6
|
Delayed or excessive hemorrhage following complete or unspecified spontaneous abortion
|
O03.7
|
Embolism following complete or unspecified spontaneous abortion
|
O03.81
|
Shock following complete or unspecified spontaneous abortion
|
O03.82
|
Renal failure following complete or unspecified spontaneous abortion
|
O03.83
|
Metabolic disorder following complete or unspecified spontaneous abortion
|
O03.84
|
Damage to pelvic organs following complete or unspecified spontaneous abortion
|
O03.85
|
Other venous complications following complete or unspecified spontaneous abortion
|
O03.86
|
Cardiac arrest following complete or unspecified spontaneous abortion
|
O04.6
|
Delayed or excessive hemorrhage following (induced) termination of pregnancy
|
O04.7
|
Embolism following (induced) termination of pregnancy
|
O04.81
|
Shock following (induced) termination of pregnancy
|
O04.82
|
Renal failure following (induced) termination of pregnancy
|
O04.83
|
Metabolic disorder following (induced) termination of pregnancy
|
O04.85
|
Other venous complications following (induced) termination of pregnancy
|
O04.86
|
Cardiac arrest following (induced) termination of pregnancy
|
O04.89
|
(Induced) termination of pregnancy with other complications
|
O07.1
|
Delayed or excessive hemorrhage following failed attempted termination of pregnancy
|
O07.2
|
Embolism following failed attempted termination of pregnancy
|
O07.31
|
Shock following failed attempted termination of pregnancy
|
O07.32
|
Renal failure following failed attempted termination of pregnancy
|
O07.33
|
Metabolic disorder following failed attempted termination of pregnancy
|
O07.35
|
Other venous complications following failed attempted termination of pregnancy
|
O07.36
|
Cardiac arrest following failed attempted termination of pregnancy
|
O07.39
|
Failed attempted termination of pregnancy with other complications
|
O08.1
|
Delayed or excessive hemorrhage following ectopic and molar pregnancy
|
O08.2
|
Embolism following ectopic and molar pregnancy
|
O08.3
|
Shock following ectopic and molar pregnancy
|
O08.4
|
Renal failure following ectopic and molar pregnancy
|
O08.5
|
Metabolic disorders following an ectopic and molar pregnancy
|
O08.7
|
Other venous complications following an ectopic and molar pregnancy
|
O08.81
|
Cardiac arrest following an ectopic and molar pregnancy
|
O08.89
|
Other complications following an ectopic and molar pregnancy
|
O09.01
|
Supervision of pregnancy with history of infertility, first trimester
|
O09.02
|
Supervision of pregnancy with history of infertility, second trimester
|
O09.03
|
Supervision of pregnancy with history of infertility, third trimester
|
O09.11
|
Supervision of pregnancy with history of ectopic pregnancy, first trimester
|
O09.12
|
Supervision of pregnancy with history of ectopic pregnancy, second trimester
|
O09.13
|
Supervision of pregnancy with history of ectopic pregnancy, third trimester
|
O09.211
|
Supervision of pregnancy with history of pre-term labor, first trimester
|
O09.212
|
Supervision of pregnancy with history of pre-term labor, second trimester
|
O09.213
|
Supervision of pregnancy with history of pre-term labor, third trimester
|
O09.291
|
Supervision of pregnancy with other poor reproductive or obstetric history, first trimester
|
O09.292
|
Supervision of pregnancy with other poor reproductive or obstetric history, second trimester
|
O09.293
|
Supervision of pregnancy with other poor reproductive or obstetric history, third trimester
|
O09.31
|
Supervision of pregnancy with insufficient antenatal care, first trimester
|
O09.32
|
Supervision of pregnancy with insufficient antenatal care, second trimester
|
O09.33
|
Supervision of pregnancy with insufficient antenatal care, third trimester
|
O09.41
|
Supervision of pregnancy with grand multiparity, first trimester
|
O09.42
|
Supervision of pregnancy with grand multiparity, second trimester
|
O09.43
|
Supervision of pregnancy with grand multiparity, third trimester
|
O09.511
|
Supervision of elderly primigravida, first trimester
|
O09.512
|
Supervision of elderly primigravida, second trimester
|
O09.513
|
Supervision of elderly primigravida, third trimester
|
O09.521
|
Supervision of elderly multigravida, first trimester
|
O09.522
|
Supervision of elderly multigravida, second trimester
|
O09.523
|
Supervision of elderly multigravida, third trimester
|
O09.611
|
Supervision of young primigravida, first trimester
|
O09.612
|
Supervision of young primigravida, second trimester
|
O09.613
|
Supervision of young primigravida, third trimester
|
O09.621
|
Supervision of young multigravida, first trimester
|
O09.622
|
Supervision of young multigravida, second trimester
|
O09.623
|
Supervision of young multigravida, third trimester
|
O09.71
|
Supervision of high risk pregnancy due to social problems, first trimester
|
O09.72
|
Supervision of high risk pregnancy due to social problems, second trimester
|
O09.73
|
Supervision of high risk pregnancy due to social problems, third trimester
|
O09.891
|
Supervision of other high risk pregnancies, first trimester
|
O09.892
|
Supervision of other high risk pregnancies, second trimester
|
O09.893
|
Supervision of other high risk pregnancies, third trimester
|
O10.011
|
Pre-existing essential hypertension complicating pregnancy, first trimester
|
O10.012
|
Pre-existing essential hypertension complicating pregnancy, second trimester
|
O10.013
|
Pre-existing essential hypertension complicating pregnancy, third trimester
|
O10.02
|
Pre-existing essential hypertension complicating childbirth
|
O10.03
|
Pre-existing essential hypertension complicating the puerperium
|
O10.111
|
Pre-existing hypertensive heart disease complicating pregnancy, first trimester
|
O10.112
|
Pre-existing hypertensive heart disease complicating pregnancy, second trimester
|
O10.113
|
Pre-existing hypertensive heart disease complicating pregnancy, third trimester
|
O10.12
|
Pre-existing hypertensive heart disease complicating childbirth
|
O10.13
|
Pre-existing hypertensive heart disease complicating the puerperium
|
O10.211
|
Pre-existing hypertensive chronic kidney disease complicating pregnancy, first trimester
|
O10.212
|
Pre-existing hypertensive chronic kidney disease complicating pregnancy, second trimester
|
O10.213
|
Pre-existing hypertensive chronic kidney disease complicating pregnancy, third trimester
|
O10.22
|
Pre-existing hypertensive chronic kidney disease complicating childbirth
|
O10.23
|
Pre-existing hypertensive chronic kidney disease complicating the puerperium
|
O10.311
|
Pre-existing hypertensive heart and chronic kidney disease complicating pregnancy, first trimester
|
O10.312
|
Pre-existing hypertensive heart and chronic kidney disease complicating pregnancy, second trimester
|
O10.313
|
Pre-existing hypertensive heart and chronic kidney disease complicating pregnancy, third trimester
|
O10.32
|
Pre-existing hypertensive heart and chronic kidney disease complicating childbirth
|
O10.33
|
Pre-existing hypertensive heart and chronic kidney disease complicating the puerperium
|
O10.411
|
Pre-existing secondary hypertension complicating pregnancy, first trimester
|
O10.412
|
Pre-existing secondary hypertension complicating pregnancy, second trimester
|
O10.413
|
Pre-existing secondary hypertension complicating pregnancy, third trimester
|
O10.42
|
Pre-existing secondary hypertension complicating childbirth
|
O10.43
|
Pre-existing secondary hypertension complicating the puerperium
|
O11.1
|
Pre-existing hypertension with pre-eclampsia, first trimester
|
O11.2
|
Pre-existing hypertension with pre-eclampsia, second trimester
|
O11.3
|
Pre-existing hypertension with pre-eclampsia, third trimester
|
O12.11
|
Gestational proteinuria, first trimester
|
O12.12
|
Gestational proteinuria, second trimester
|
O12.13
|
Gestational proteinuria, third trimester
|
O12.21
|
Gestational edema with proteinuria, first trimester
|
O12.22
|
Gestational edema with proteinuria, second trimester
|
O12.23
|
Gestational edema with proteinuria, third trimester
|
O13.1
|
Gestational [pregnancy-induced] hypertension without significant proteinuria, first trimester
|
O13.2
|
Gestational [pregnancy-induced] hypertension without significant proteinuria, second trimester
|
O13.3
|
Gestational [pregnancy-induced] hypertension without significant proteinuria, third trimester
|
O14.02
|
Mild to moderate pre-eclampsia, second trimester
|
O14.03
|
Mild to moderate pre-eclampsia, third trimester
|
O14.12
|
Severe pre-eclampsia, second trimester
|
O14.13
|
Severe pre-eclampsia, third trimester
|
O14.22
|
HELLP syndrome (HELLP), second trimester
|
O14.23
|
HELLP syndrome (HELLP), third trimester
|
O15.02
|
Eclampsia complicating pregnancy, second trimester
|
O15.03
|
Eclampsia complicating pregnancy, third trimester
|
O15.1
|
Eclampsia complicating labor
|
O15.2
|
Eclampsia complicating the puerperium
|
O20.0
|
Threatened abortion
|
O20.8
|
Other hemorrhage in early pregnancy
|
O21.0
|
Mild hyperemesis gravidarum
|
O21.1
|
Hyperemesis gravidarum with metabolic disturbance
|
O21.2
|
Late vomiting of pregnancy
|
O21.8
|
Other vomiting complicating pregnancy
|
O24.011
|
Pre-existing type 1 diabetes mellitus, in pregnancy, first trimester
|
O24.012
|
Pre-existing type 1 diabetes mellitus, in pregnancy, second trimester
|
O24.013
|
Pre-existing type 1 diabetes mellitus, in pregnancy, third trimester
|
O24.02
|
Pre-existing type 1 diabetes mellitus, in childbirth
|
O24.03
|
Pre-existing type 1 diabetes mellitus, in the puerperium
|
O24.111
|
Pre-existing type 2 diabetes mellitus, in pregnancy, first trimester
|
O24.112
|
Pre-existing type 2 diabetes mellitus, in pregnancy, second trimester
|
O24.113
|
Pre-existing type 2 diabetes mellitus, in pregnancy, third trimester
|
O24.12
|
Pre-existing type 2 diabetes mellitus, in childbirth
|
O24.13
|
Pre-existing type 2 diabetes mellitus, in the puerperium
|
O24.811
|
Other pre-existing diabetes mellitus in pregnancy, first trimester
|
O24.812
|
Other pre-existing diabetes mellitus in pregnancy, second trimester
|
O24.813
|
Other pre-existing diabetes mellitus in pregnancy, third trimester
|
O24.82
|
Other pre-existing diabetes mellitus in childbirth
|
O24.83
|
Other pre-existing diabetes mellitus in the puerperium
|
O25.11
|
Malnutrition in pregnancy, first trimester
|
O25.12
|
Malnutrition in pregnancy, second trimester
|
O25.13
|
Malnutrition in pregnancy, third trimester
|
O25.2
|
Malnutrition in childbirth
|
O25.3
|
Malnutrition in the puerperium
|
O26.11
|
Low weight gain in pregnancy, first trimester
|
O26.12
|
Low weight gain in pregnancy, second trimester
|
O26.13
|
Low weight gain in pregnancy, third trimester
|
O26.31
|
Retained intrauterine contraceptive device in pregnancy, first trimester
|
O26.32
|
Retained intrauterine contraceptive device in pregnancy, second trimester
|
O26.33
|
Retained intrauterine contraceptive device in pregnancy, third trimester
|
O26.41
|
Herpes gestationis, first trimester
|
O26.42
|
Herpes gestationis, second trimester
|
O26.43
|
Herpes gestationis, third trimester
|
O26.51
|
Maternal hypotension syndrome, first trimester
|
O26.52
|
Maternal hypotension syndrome, second trimester
|
O26.53
|
Maternal hypotension syndrome, third trimester
|
O26.63
|
Liver and biliary tract disorders in the puerperium
|
O26.811
|
Pregnancy related exhaustion and fatigue, first trimester
|
O26.812
|
Pregnancy related exhaustion and fatigue, second trimester
|
O26.813
|
Pregnancy related exhaustion and fatigue, third trimester
|
O26.831
|
Pregnancy related renal disease, first trimester
|
O26.832
|
Pregnancy related renal disease, second trimester
|
O26.833
|
Pregnancy related renal disease, third trimester
|
O29.111
|
Cardiac arrest due to anesthesia during pregnancy, first trimester
|
O29.112
|
Cardiac arrest due to anesthesia during pregnancy, second trimester
|
O29.113
|
Cardiac arrest due to anesthesia during pregnancy, third trimester
|
O29.121
|
Cardiac failure due to anesthesia during pregnancy, first trimester
|
O29.122
|
Cardiac failure due to anesthesia during pregnancy, second trimester
|
O29.123
|
Cardiac failure due to anesthesia during pregnancy, third trimester
|
O29.191
|
Other cardiac complications of anesthesia during pregnancy, first trimester
|
O29.192
|
Other cardiac complications of anesthesia during pregnancy, second trimester
|
O29.193
|
Other cardiac complications of anesthesia during pregnancy, third trimester
|
O29.211
|
Cerebral anoxia due to anesthesia during pregnancy, first trimester
|
O29.212
|
Cerebral anoxia due to anesthesia during pregnancy, second trimester
|
O29.213
|
Cerebral anoxia due to anesthesia during pregnancy, third trimester
|
O29.291
|
Other central nervous system complications of anesthesia during pregnancy, first trimester
|
O29.292
|
Other central nervous system complications of anesthesia during pregnancy, second trimester
|
O29.293
|
Other central nervous system complications of anesthesia during pregnancy, third trimester
|
O29.3X1
|
Toxic reaction to local anesthesia during pregnancy, first trimester
|
O29.3X2
|
Toxic reaction to local anesthesia during pregnancy, second trimester
|
O29.3X3
|
Toxic reaction to local anesthesia during pregnancy, third trimester
|
O44.11
|
Complete placenta previa with hemorrhage, first trimester
|
O44.12
|
Complete placenta previa with hemorrhage, second trimester
|
O44.13
|
Complete placenta previa with hemorrhage, third trimester
|
O45.011
|
Premature separation of placenta with afibrinogenemia, first trimester
|
O45.012
|
Premature separation of placenta with afibrinogenemia, second trimester
|
O45.013
|
Premature separation of placenta with afibrinogenemia, third trimester
|
O45.021
|
Premature separation of placenta with disseminated intravascular coagulation, first trimester
|
O45.022
|
Premature separation of placenta with disseminated intravascular coagulation, second trimester
|
O45.023
|
Premature separation of placenta with disseminated intravascular coagulation, third trimester
|
O45.091
|
Premature separation of placenta with other coagulation defect, first trimester
|
O45.092
|
Premature separation of placenta with other coagulation defect, second trimester
|
O45.093
|
Premature separation of placenta with other coagulation defect, third trimester
|
O45.8X1
|
Other premature separation of placenta, first trimester
|
O45.8X2
|
Other premature separation of placenta, second trimester
|
O45.8X3
|
Other premature separation of placenta, third trimester
|
O46.011
|
Antepartum hemorrhage with afibrinogenemia, first trimester
|
O46.012
|
Antepartum hemorrhage with afibrinogenemia, second trimester
|
O46.013
|
Antepartum hemorrhage with afibrinogenemia, third trimester
|
O46.021
|
Antepartum hemorrhage with disseminated intravascular coagulation, first trimester
|
O46.022
|
Antepartum hemorrhage with disseminated intravascular coagulation, second trimester
|
O46.023
|
Antepartum hemorrhage with disseminated intravascular coagulation, third trimester
|
O46.091
|
Antepartum hemorrhage with other coagulation defect, first trimester
|
O46.092
|
Antepartum hemorrhage with other coagulation defect, second trimester
|
O46.093
|
Antepartum hemorrhage with other coagulation defect, third trimester
|
O46.8X1
|
Other antepartum hemorrhage, first trimester
|
O46.8X2
|
Other antepartum hemorrhage, second trimester
|
O46.8X3
|
Other antepartum hemorrhage, third trimester
|
O67.0
|
Intrapartum hemorrhage with coagulation defect
|
O67.8
|
Other intrapartum hemorrhage
|
O72.0
|
Third-stage hemorrhage
|
O72.1
|
Other immediate postpartum hemorrhage
|
O72.2
|
Delayed and secondary postpartum hemorrhage
|
O74.2
|
Cardiac complications of anesthesia during labor and delivery
|
O74.4
|
Toxic reaction to local anesthesia during labor and delivery
|
O75.1
|
Shock during or following labor and delivery
|
O75.4
|
Other complications of obstetric surgery and procedures
|
O75.81
|
Maternal exhaustion complicating labor and delivery
|
O75.89
|
Other specified complications of labor and delivery
|
O88.211
|
Thromboembolism in pregnancy, first trimester
|
O88.212
|
Thromboembolism in pregnancy, second trimester
|
O88.213
|
Thromboembolism in pregnancy, third trimester
|
O88.22
|
Thromboembolism in childbirth
|
O88.23
|
Thromboembolism in the puerperium
|
O89.1
|
Cardiac complications of anesthesia during the puerperium
|
O89.3
|
Toxic reaction to local anesthesia during the puerperium
|
O90.41
|
Hepatorenal syndrome following labor and delivery
|
O90.89
|
Other complications of the puerperium, not elsewhere classified
|
O99.281
|
Endocrine, nutritional and metabolic diseases complicating pregnancy, first trimester
|
O99.282
|
Endocrine, nutritional and metabolic diseases complicating pregnancy, second trimester
|
O99.283
|
Endocrine, nutritional and metabolic diseases complicating pregnancy, third trimester
|
O99.284
|
Endocrine, nutritional and metabolic diseases complicating childbirth
|
O99.285
|
Endocrine, nutritional and metabolic diseases complicating the puerperium
|
O99.321
|
Drug use complicating pregnancy, first trimester
|
O99.322
|
Drug use complicating pregnancy, second trimester
|
O99.323
|
Drug use complicating pregnancy, third trimester
|
O99.324
|
Drug use complicating childbirth
|
O99.325
|
Drug use complicating the puerperium
|
O99.351
|
Diseases of the nervous system complicating pregnancy, first trimester
|
O99.352
|
Diseases of the nervous system complicating pregnancy, second trimester
|
O99.353
|
Diseases of the nervous system complicating pregnancy, third trimester
|
O99.354
|
Diseases of the nervous system complicating childbirth
|
O99.355
|
Diseases of the nervous system complicating the puerperium
|
O99.511
|
Diseases of the respiratory system complicating pregnancy, first trimester
|
O99.512
|
Diseases of the respiratory system complicating pregnancy, second trimester
|
O99.513
|
Diseases of the respiratory system complicating pregnancy, third trimester
|
O99.52
|
Diseases of the respiratory system complicating childbirth
|
O99.53
|
Diseases of the respiratory system complicating the puerperium
|
O99.611
|
Diseases of the digestive system complicating pregnancy, first trimester
|
O99.612
|
Diseases of the digestive system complicating pregnancy, second trimester
|
O99.613
|
Diseases of the digestive system complicating pregnancy, third trimester
|
O99.62
|
Diseases of the digestive system complicating childbirth
|
O99.63
|
Diseases of the digestive system complicating the puerperium
|
O99.711
|
Diseases of the skin and subcutaneous tissue complicating pregnancy, first trimester
|
O99.712
|
Diseases of the skin and subcutaneous tissue complicating pregnancy, second trimester
|
O99.713
|
Diseases of the skin and subcutaneous tissue complicating pregnancy, third trimester
|
O99.72
|
Diseases of the skin and subcutaneous tissue complicating childbirth
|
O99.73
|
Diseases of the skin and subcutaneous tissue complicating the puerperium
|
O99.820
|
Streptococcus B carrier state complicating pregnancy
|
O99.824
|
Streptococcus B carrier state complicating childbirth
|
O99.825
|
Streptococcus B carrier state complicating the puerperium
|
O9A.111
|
Malignant neoplasm complicating pregnancy, first trimester
|
O9A.112
|
Malignant neoplasm complicating pregnancy, second trimester
|
O9A.113
|
Malignant neoplasm complicating pregnancy, third trimester
|
O9A.12
|
Malignant neoplasm complicating childbirth
|
O9A.13
|
Malignant neoplasm complicating the puerperium
|
O9A.211
|
Injury, poisoning and certain other consequences of external causes complicating pregnancy, first trimester
|
O9A.212
|
Injury, poisoning and certain other consequences of external causes complicating pregnancy, second trimester
|
O9A.213
|
Injury, poisoning and certain other consequences of external causes complicating pregnancy, third trimester
|
O9A.22
|
Injury, poisoning and certain other consequences of external causes complicating childbirth
|
O9A.23
|
Injury, poisoning and certain other consequences of external causes complicating the puerperium
|
O9A.311
|
Physical abuse complicating pregnancy, first trimester
|
O9A.312
|
Physical abuse complicating pregnancy, second trimester
|
O9A.313
|
Physical abuse complicating pregnancy, third trimester
|
O9A.32
|
Physical abuse complicating childbirth
|
O9A.33
|
Physical abuse complicating the puerperium
|
O9A.411
|
Sexual abuse complicating pregnancy, first trimester
|
O9A.412
|
Sexual abuse complicating pregnancy, second trimester
|
O9A.413
|
Sexual abuse complicating pregnancy, third trimester
|
O9A.42
|
Sexual abuse complicating childbirth
|
O9A.43
|
Sexual abuse complicating the puerperium
|
P00.0
|
Newborn affected by maternal hypertensive disorders
|
P00.1
|
Newborn affected by maternal renal and urinary tract diseases
|
P00.4
|
Newborn affected by maternal nutritional disorders
|
P00.81
|
Newborn affected by periodontal disease in mother
|
P00.82
|
Newborn affected by (positive) maternal group B streptococcus (GBS) colonization
|
P00.89
|
Newborn affected by other maternal conditions
|
P03.810
|
Newborn affected by abnormality in fetal (intrauterine) heart rate or rhythm before the onset of labor
|
P03.811
|
Newborn affected by abnormality in fetal (intrauterine) heart rate or rhythm during labor
|
P03.82
|
Meconium passage during delivery
|
P03.89
|
Newborn affected by other specified complications of labor and delivery
|
P04.3
|
Newborn affected by maternal use of alcohol
|
P92.01
|
Bilious vomiting of newborn
|
P92.09
|
Other vomiting of newborn
|
P96.81
|
Exposure to (parental) (environmental) tobacco smoke in the perinatal period
|
Q61.2
|
Polycystic kidney, adult type
|
Q86.0
|
Fetal alcohol syndrome (dysmorphic)
|
R03.0
|
Elevated blood-pressure reading, without diagnosis of hypertension
|
R11.14
|
Bilious vomiting
|
R11.15
|
Cyclical vomiting syndrome unrelated to migraine
|
R19.7
|
Diarrhea, unspecified
|
R25.0
|
Abnormal head movements
|
R25.2
|
Cramp and spasm
|
R25.3
|
Fasciculation
|
R25.8
|
Other abnormal involuntary movements
|
R29.0
|
Tetany
|
R29.898
|
Other symptoms and signs involving the musculoskeletal system
|
R40.0
|
Somnolence
|
R40.1
|
Stupor
|
R40.2111
|
Coma scale, eyes open, never, in the field [EMT or ambulance]
|
R40.2112
|
Coma scale, eyes open, never, at arrival to emergency department
|
R40.2113
|
Coma scale, eyes open, never, at hospital admission
|
R40.2114
|
Coma scale, eyes open, never, 24 hours or more after hospital admission
|
R40.2121
|
Coma scale, eyes open, to pain, in the field [EMT or ambulance]
|
R40.2122
|
Coma scale, eyes open, to pain, at arrival to emergency department
|
R40.2123
|
Coma scale, eyes open, to pain, at hospital admission
|
R40.2124
|
Coma scale, eyes open, to pain, 24 hours or more after hospital admission
|
R40.2211
|
Coma scale, best verbal response, none, in the field [EMT or ambulance]
|
R40.2212
|
Coma scale, best verbal response, none, at arrival to emergency department
|
R40.2213
|
Coma scale, best verbal response, none, at hospital admission
|
R40.2214
|
Coma scale, best verbal response, none, 24 hours or more after hospital admission
|
R40.2221
|
Coma scale, best verbal response, incomprehensible words, in the field [EMT or ambulance]
|
R40.2222
|
Coma scale, best verbal response, incomprehensible words, at arrival to emergency department
|
R40.2223
|
Coma scale, best verbal response, incomprehensible words, at hospital admission
|
R40.2224
|
Coma scale, best verbal response, incomprehensible words, 24 hours or more after hospital admission
|
R40.2311
|
Coma scale, best motor response, none, in the field [EMT or ambulance]
|
R40.2312
|
Coma scale, best motor response, none, at arrival to emergency department
|
R40.2313
|
Coma scale, best motor response, none, at hospital admission
|
R40.2314
|
Coma scale, best motor response, none, 24 hours or more after hospital admission
|
R40.2321
|
Coma scale, best motor response, extension, in the field [EMT or ambulance]
|
R40.2322
|
Coma scale, best motor response, extension, at arrival to emergency department
|
R40.2323
|
Coma scale, best motor response, extension, at hospital admission
|
R40.2324
|
Coma scale, best motor response, extension, 24 hours or more after hospital admission
|
R40.2341
|
Coma scale, best motor response, flexion withdrawal, in the field [EMT or ambulance]
|
R40.2342
|
Coma scale, best motor response, flexion withdrawal, at arrival to emergency department
|
R40.2343
|
Coma scale, best motor response, flexion withdrawal, at hospital admission
|
R40.2344
|
Coma scale, best motor response, flexion withdrawal, 24 hours or more after hospital admission
|
R40.4
|
Transient alteration of awareness
|
R41.0
|
Disorientation, unspecified
|
R53.0
|
Neoplastic (malignant) related fatigue
|
R53.1
|
Weakness
|
R53.81
|
Other malaise
|
R53.83
|
Other fatigue
|
R55
|
Syncope and collapse
|
R56.00
|
Simple febrile convulsions
|
R56.01
|
Complex febrile convulsions
|
R57.0
|
Cardiogenic shock
|
R57.1
|
Hypovolemic shock
|
R57.8
|
Other shock
|
R63.0
|
Anorexia
|
R63.4
|
Abnormal weight loss
|
R63.6
|
Underweight
|
R63.8
|
Other symptoms and signs concerning food and fluid intake
|
R64
|
Cachexia
|
R78.71
|
Abnormal lead level in blood
|
R78.79
|
Finding of abnormal level of heavy metals in blood
|
R78.89
|
Finding of other specified substances, not normally found in blood
|
R79.0
|
Abnormal level of blood mineral
|
R79.83
|
Abnormal findings of blood amino-acid level
|
R79.89
|
Other specified abnormal findings of blood chemistry
|
R94.31
|
Abnormal electrocardiogram [ECG] [EKG]
|
R94.4
|
Abnormal results of kidney function studies
|
T36.0X5A
|
Adverse effect of penicillins, initial encounter
|
T36.0X5D
|
Adverse effect of penicillins, subsequent encounter
|
T36.0X5S
|
Adverse effect of penicillins, sequela
|
T36.1X5A
|
Adverse effect of cephalosporins and other beta-lactam antibiotics, initial encounter
|
T36.1X5D
|
Adverse effect of cephalosporins and other beta-lactam antibiotics, subsequent encounter
|
T36.1X5S
|
Adverse effect of cephalosporins and other beta-lactam antibiotics, sequela
|
T36.2X5A
|
Adverse effect of chloramphenicol group, initial encounter
|
T36.2X5D
|
Adverse effect of chloramphenicol group, subsequent encounter
|
T36.2X5S
|
Adverse effect of chloramphenicol group, sequela
|
T36.3X5A
|
Adverse effect of macrolides, initial encounter
|
T36.3X5D
|
Adverse effect of macrolides, subsequent encounter
|
T36.3X5S
|
Adverse effect of macrolides, sequela
|
T36.4X5A
|
Adverse effect of tetracyclines, initial encounter
|
T36.4X5D
|
Adverse effect of tetracyclines, subsequent encounter
|
T36.4X5S
|
Adverse effect of tetracyclines, sequela
|
T36.5X5A
|
Adverse effect of aminoglycosides, initial encounter
|
T36.5X5D
|
Adverse effect of aminoglycosides, subsequent encounter
|
T36.5X5S
|
Adverse effect of aminoglycosides, sequela
|
T36.6X5A
|
Adverse effect of rifampicins, initial encounter
|
T36.6X5D
|
Adverse effect of rifampicins, subsequent encounter
|
T36.6X5S
|
Adverse effect of rifampicins, sequela
|
T36.7X5A
|
Adverse effect of antifungal antibiotics, systemically used, initial encounter
|
T36.7X5D
|
Adverse effect of antifungal antibiotics, systemically used, subsequent encounter
|
T36.7X5S
|
Adverse effect of antifungal antibiotics, systemically used, sequela
|
T36.8X5A
|
Adverse effect of other systemic antibiotics, initial encounter
|
T36.8X5D
|
Adverse effect of other systemic antibiotics, subsequent encounter
|
T36.8X5S
|
Adverse effect of other systemic antibiotics, sequela
|
T37.0X5A
|
Adverse effect of sulfonamides, initial encounter
|
T37.0X5D
|
Adverse effect of sulfonamides, subsequent encounter
|
T37.0X5S
|
Adverse effect of sulfonamides, sequela
|
T37.1X5A
|
Adverse effect of antimycobacterial drugs, initial encounter
|
T37.1X5D
|
Adverse effect of antimycobacterial drugs, subsequent encounter
|
T37.1X5S
|
Adverse effect of antimycobacterial drugs, sequela
|
T37.2X5A
|
Adverse effect of antimalarials and drugs acting on other blood protozoa, initial encounter
|
T37.2X5D
|
Adverse effect of antimalarials and drugs acting on other blood protozoa, subsequent encounter
|
T37.2X5S
|
Adverse effect of antimalarials and drugs acting on other blood protozoa, sequela
|
T37.3X5A
|
Adverse effect of other antiprotozoal drugs, initial encounter
|
T37.3X5D
|
Adverse effect of other antiprotozoal drugs, subsequent encounter
|
T37.3X5S
|
Adverse effect of other antiprotozoal drugs, sequela
|
T37.4X5A
|
Adverse effect of anthelminthics, initial encounter
|
T37.4X5D
|
Adverse effect of anthelminthics, subsequent encounter
|
T37.4X5S
|
Adverse effect of anthelminthics, sequela
|
T37.5X5A
|
Adverse effect of antiviral drugs, initial encounter
|
T37.5X5D
|
Adverse effect of antiviral drugs, subsequent encounter
|
T37.5X5S
|
Adverse effect of antiviral drugs, sequela
|
T37.8X5A
|
Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter
|
T37.8X5D
|
Adverse effect of other specified systemic anti-infectives and antiparasitics, subsequent encounter
|
T37.8X5S
|
Adverse effect of other specified systemic anti-infectives and antiparasitics, sequela
|
T38.0X5A
|
Adverse effect of glucocorticoids and synthetic analogues, initial encounter
|
T38.0X5D
|
Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter
|
T38.0X5S
|
Adverse effect of glucocorticoids and synthetic analogues, sequela
|
T38.1X5A
|
Adverse effect of thyroid hormones and substitutes, initial encounter
|
T38.1X5D
|
Adverse effect of thyroid hormones and substitutes, subsequent encounter
|
T38.1X5S
|
Adverse effect of thyroid hormones and substitutes, sequela
|
T38.2X5A
|
Adverse effect of antithyroid drugs, initial encounter
|
T38.2X5D
|
Adverse effect of antithyroid drugs, subsequent encounter
|
T38.2X5S
|
Adverse effect of antithyroid drugs, sequela
|
T38.3X5A
|
Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter
|
T38.3X5D
|
Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, subsequent encounter
|
T38.3X5S
|
Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, sequela
|
T38.4X5A
|
Adverse effect of oral contraceptives, initial encounter
|
T38.4X5D
|
Adverse effect of oral contraceptives, subsequent encounter
|
T38.4X5S
|
Adverse effect of oral contraceptives, sequela
|
T38.5X5A
|
Adverse effect of other estrogens and progestogens, initial encounter
|
T38.5X5D
|
Adverse effect of other estrogens and progestogens, subsequent encounter
|
T38.5X5S
|
Adverse effect of other estrogens and progestogens, sequela
|
T38.6X5A
|
Adverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, initial encounter
|
T38.6X5D
|
Adverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, subsequent encounter
|
T38.6X5S
|
Adverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, sequela
|
T38.7X5A
|
Adverse effect of androgens and anabolic congeners, initial encounter
|
T38.7X5D
|
Adverse effect of androgens and anabolic congeners, subsequent encounter
|
T38.7X5S
|
Adverse effect of androgens and anabolic congeners, sequela
|
T38.815A
|
Adverse effect of anterior pituitary [adenohypophyseal] hormones, initial encounter
|
T38.815D
|
Adverse effect of anterior pituitary [adenohypophyseal] hormones, subsequent encounter
|
T38.815S
|
Adverse effect of anterior pituitary [adenohypophyseal] hormones, sequela
|
T38.895A
|
Adverse effect of other hormones and synthetic substitutes, initial encounter
|
T38.895D
|
Adverse effect of other hormones and synthetic substitutes, subsequent encounter
|
T38.895S
|
Adverse effect of other hormones and synthetic substitutes, sequela
|
T39.095A
|
Adverse effect of salicylates, initial encounter
|
T39.095D
|
Adverse effect of salicylates, subsequent encounter
|
T39.095S
|
Adverse effect of salicylates, sequela
|
T39.1X5A
|
Adverse effect of 4-Aminophenol derivatives, initial encounter
|
T39.1X5D
|
Adverse effect of 4-Aminophenol derivatives, subsequent encounter
|
T39.1X5S
|
Adverse effect of 4-Aminophenol derivatives, sequela
|
T39.2X5A
|
Adverse effect of pyrazolone derivatives, initial encounter
|
T39.2X5D
|
Adverse effect of pyrazolone derivatives, subsequent encounter
|
T39.2X5S
|
Adverse effect of pyrazolone derivatives, sequela
|
T39.315A
|
Adverse effect of propionic acid derivatives, initial encounter
|
T39.315D
|
Adverse effect of propionic acid derivatives, subsequent encounter
|
T39.315S
|
Adverse effect of propionic acid derivatives, sequela
|
T39.395A
|
Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter
|
T39.395D
|
Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], subsequent encounter
|
T39.395S
|
Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], sequela
|
T39.4X5A
|
Adverse effect of antirheumatics, not elsewhere classified, initial encounter
|
T39.4X5D
|
Adverse effect of antirheumatics, not elsewhere classified, subsequent encounter
|
T39.4X5S
|
Adverse effect of antirheumatics, not elsewhere classified, sequela
|
T39.8X5A
|
Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, initial encounter
|
T39.8X5D
|
Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, subsequent encounter
|
T39.8X5S
|
Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, sequela
|
T40.0X5A
|
Adverse effect of opium, initial encounter
|
T40.0X5D
|
Adverse effect of opium, subsequent encounter
|
T40.0X5S
|
Adverse effect of opium, sequela
|
T40.2X5A
|
Adverse effect of other opioids, initial encounter
|
T40.2X5D
|
Adverse effect of other opioids, subsequent encounter
|
T40.2X5S
|
Adverse effect of other opioids, sequela
|
T40.3X5A
|
Adverse effect of methadone, initial encounter
|
T40.3X5D
|
Adverse effect of methadone, subsequent encounter
|
T40.3X5S
|
Adverse effect of methadone, sequela
|
T40.5X5A
|
Adverse effect of cocaine, initial encounter
|
T40.5X5D
|
Adverse effect of cocaine, subsequent encounter
|
T40.5X5S
|
Adverse effect of cocaine, sequela
|
T40.695A
|
Adverse effect of other narcotics, initial encounter
|
T40.695D
|
Adverse effect of other narcotics, subsequent encounter
|
T40.695S
|
Adverse effect of other narcotics, sequela
|
T40.995A
|
Adverse effect of other psychodysleptics [hallucinogens], initial encounter
|
T40.995D
|
Adverse effect of other psychodysleptics [hallucinogens], subsequent encounter
|
T40.995S
|
Adverse effect of other psychodysleptics [hallucinogens], sequela
|
T41.5X5A
|
Adverse effect of therapeutic gases, initial encounter
|
T41.5X5D
|
Adverse effect of therapeutic gases, subsequent encounter
|
T41.5X5S
|
Adverse effect of therapeutic gases, sequela
|
T42.0X5A
|
Adverse effect of hydantoin derivatives, initial encounter
|
T42.0X5D
|
Adverse effect of hydantoin derivatives, subsequent encounter
|
T42.0X5S
|
Adverse effect of hydantoin derivatives, sequela
|
T42.1X5A
|
Adverse effect of iminostilbenes, initial encounter
|
T42.1X5D
|
Adverse effect of iminostilbenes, subsequent encounter
|
T42.1X5S
|
Adverse effect of iminostilbenes, sequela
|
T42.2X5A
|
Adverse effect of succinimides and oxazolidinediones, initial encounter
|
T42.2X5D
|
Adverse effect of succinimides and oxazolidinediones, subsequent encounter
|
T42.2X5S
|
Adverse effect of succinimides and oxazolidinediones, sequela
|
T42.3X5A
|
Adverse effect of barbiturates, initial encounter
|
T42.3X5D
|
Adverse effect of barbiturates, subsequent encounter
|
T42.3X5S
|
Adverse effect of barbiturates, sequela
|
T42.4X5A
|
Adverse effect of benzodiazepines, initial encounter
|
T42.4X5D
|
Adverse effect of benzodiazepines, subsequent encounter
|
T42.4X5S
|
Adverse effect of benzodiazepines, sequela
|
T42.5X5A
|
Adverse effect of mixed antiepileptics, initial encounter
|
T42.5X5D
|
Adverse effect of mixed antiepileptics, subsequent encounter
|
T42.5X5S
|
Adverse effect of mixed antiepileptics, sequela
|
T42.6X5A
|
Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter
|
T42.6X5D
|
Adverse effect of other antiepileptic and sedative-hypnotic drugs, subsequent encounter
|
T42.6X5S
|
Adverse effect of other antiepileptic and sedative-hypnotic drugs, sequela
|
T42.8X5A
|
Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter
|
T42.8X5D
|
Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, subsequent encounter
|
T42.8X5S
|
Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, sequela
|
T43.015A
|
Adverse effect of tricyclic antidepressants, initial encounter
|
T43.015D
|
Adverse effect of tricyclic antidepressants, subsequent encounter
|
T43.015S
|
Adverse effect of tricyclic antidepressants, sequela
|
T43.025A
|
Adverse effect of tetracyclic antidepressants, initial encounter
|
T43.025D
|
Adverse effect of tetracyclic antidepressants, subsequent encounter
|
T43.025S
|
Adverse effect of tetracyclic antidepressants, sequela
|
T43.1X5A
|
Adverse effect of monoamine-oxidase-inhibitor antidepressants, initial encounter
|
T43.1X5D
|
Adverse effect of monoamine-oxidase-inhibitor antidepressants, subsequent encounter
|
T43.1X5S
|
Adverse effect of monoamine-oxidase-inhibitor antidepressants, sequela
|
T43.215A
|
Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter
|
T43.215D
|
Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, subsequent encounter
|
T43.215S
|
Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, sequela
|
T43.225A
|
Adverse effect of selective serotonin reuptake inhibitors, initial encounter
|
T43.225D
|
Adverse effect of selective serotonin reuptake inhibitors, subsequent encounter
|
T43.225S
|
Adverse effect of selective serotonin reuptake inhibitors, sequela
|
T43.295A
|
Adverse effect of other antidepressants, initial encounter
|
T43.295D
|
Adverse effect of other antidepressants, subsequent encounter
|
T43.295S
|
Adverse effect of other antidepressants, sequela
|
T43.3X5A
|
Adverse effect of phenothiazine antipsychotics and neuroleptics, initial encounter
|
T43.3X5D
|
Adverse effect of phenothiazine antipsychotics and neuroleptics, subsequent encounter
|
T43.3X5S
|
Adverse effect of phenothiazine antipsychotics and neuroleptics, sequela
|
T43.4X5A
|
Adverse effect of butyrophenone and thiothixene neuroleptics, initial encounter
|
T43.4X5D
|
Adverse effect of butyrophenone and thiothixene neuroleptics, subsequent encounter
|
T43.4X5S
|
Adverse effect of butyrophenone and thiothixene neuroleptics, sequela
|
T43.595A
|
Adverse effect of other antipsychotics and neuroleptics, initial encounter
|
T43.595D
|
Adverse effect of other antipsychotics and neuroleptics, subsequent encounter
|
T43.595S
|
Adverse effect of other antipsychotics and neuroleptics, sequela
|
T43.615A
|
Adverse effect of caffeine, initial encounter
|
T43.615D
|
Adverse effect of caffeine, subsequent encounter
|
T43.615S
|
Adverse effect of caffeine, sequela
|
T43.625A
|
Adverse effect of amphetamines, initial encounter
|
T43.625D
|
Adverse effect of amphetamines, subsequent encounter
|
T43.625S
|
Adverse effect of amphetamines, sequela
|
T43.635A
|
Adverse effect of methylphenidate, initial encounter
|
T43.635D
|
Adverse effect of methylphenidate, subsequent encounter
|
T43.635S
|
Adverse effect of methylphenidate, sequela
|
T43.651A
|
Poisoning by methamphetamines accidental (unintentional), initial encounter
|
T43.651D
|
Poisoning by methamphetamines accidental (unintentional), subsequent encounter
|
T43.651S
|
Poisoning by methamphetamines accidental (unintentional), sequela
|
T43.652A
|
Poisoning by methamphetamines intentional self-harm, initial encounter
|
T43.652D
|
Poisoning by methamphetamines intentional self-harm, subsequent encounter
|
T43.652S
|
Poisoning by methamphetamines intentional self-harm, sequela
|
T43.653A
|
Poisoning by methamphetamines, assault, initial encounter
|
T43.653D
|
Poisoning by methamphetamines, assault, subsequent encounter
|
T43.653S
|
Poisoning by methamphetamines, assault, sequela
|
T43.654A
|
Poisoning by methamphetamines, undetermined, initial encounter
|
T43.654D
|
Poisoning by methamphetamines, undetermined, subsequent encounter
|
T43.654S
|
Poisoning by methamphetamines, undetermined, sequela
|
T43.655A
|
Adverse effect of methamphetamines, initial encounter
|
T43.655D
|
Adverse effect of methamphetamines, subsequent encounter
|
T43.655S
|
Adverse effect of methamphetamines, sequela
|
T43.695A
|
Adverse effect of other psychostimulants, initial encounter
|
T43.695D
|
Adverse effect of other psychostimulants, subsequent encounter
|
T43.695S
|
Adverse effect of other psychostimulants, sequela
|
T43.8X5A
|
Adverse effect of other psychotropic drugs, initial encounter
|
T43.8X5D
|
Adverse effect of other psychotropic drugs, subsequent encounter
|
T43.8X5S
|
Adverse effect of other psychotropic drugs, sequela
|
T44.0X5A
|
Adverse effect of anticholinesterase agents, initial encounter
|
T44.0X5D
|
Adverse effect of anticholinesterase agents, subsequent encounter
|
T44.0X5S
|
Adverse effect of anticholinesterase agents, sequela
|
T44.1X5A
|
Adverse effect of other parasympathomimetics [cholinergics], initial encounter
|
T44.1X5D
|
Adverse effect of other parasympathomimetics [cholinergics], subsequent encounter
|
T44.1X5S
|
Adverse effect of other parasympathomimetics [cholinergics], sequela
|
T44.2X5A
|
Adverse effect of ganglionic blocking drugs, initial encounter
|
T44.2X5D
|
Adverse effect of ganglionic blocking drugs, subsequent encounter
|
T44.2X5S
|
Adverse effect of ganglionic blocking drugs, sequela
|
T44.3X5A
|
Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter
|
T44.3X5D
|
Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, subsequent encounter
|
T44.3X5S
|
Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela
|
T44.4X5A
|
Adverse effect of predominantly alpha-adrenoreceptor agonists, initial encounter
|
T44.4X5D
|
Adverse effect of predominantly alpha-adrenoreceptor agonists, subsequent encounter
|
T44.4X5S
|
Adverse effect of predominantly alpha-adrenoreceptor agonists, sequela
|
T44.5X5A
|
Adverse effect of predominantly beta-adrenoreceptor agonists, initial encounter
|
T44.5X5D
|
Adverse effect of predominantly beta-adrenoreceptor agonists, subsequent encounter
|
T44.5X5S
|
Adverse effect of predominantly beta-adrenoreceptor agonists, sequela
|
T44.6X5A
|
Adverse effect of alpha-adrenoreceptor antagonists, initial encounter
|
T44.6X5D
|
Adverse effect of alpha-adrenoreceptor antagonists, subsequent encounter
|
T44.6X5S
|
Adverse effect of alpha-adrenoreceptor antagonists, sequela
|
T44.7X5A
|
Adverse effect of beta-adrenoreceptor antagonists, initial encounter
|
T44.7X5D
|
Adverse effect of beta-adrenoreceptor antagonists, subsequent encounter
|
T44.7X5S
|
Adverse effect of beta-adrenoreceptor antagonists, sequela
|
T44.8X5A
|
Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, initial encounter
|
T44.8X5D
|
Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, subsequent encounter
|
T44.8X5S
|
Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, sequela
|
T44.995A
|
Adverse effect of other drug primarily affecting the autonomic nervous system, initial encounter
|
T44.995D
|
Adverse effect of other drug primarily affecting the autonomic nervous system, subsequent encounter
|
T44.995S
|
Adverse effect of other drug primarily affecting the autonomic nervous system, sequela
|
T45.0X5A
|
Adverse effect of antiallergic and antiemetic drugs, initial encounter
|
T45.0X5D
|
Adverse effect of antiallergic and antiemetic drugs, subsequent encounter
|
T45.0X5S
|
Adverse effect of antiallergic and antiemetic drugs, sequela
|
T45.1X5A*
|
Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter
|
T45.1X5D*
|
Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter
|
T45.1X5S*
|
Adverse effect of antineoplastic and immunosuppressive drugs, sequela
|
T45.2X5A
|
Adverse effect of vitamins, initial encounter
|
T45.2X5D
|
Adverse effect of vitamins, subsequent encounter
|
T45.2X5S
|
Adverse effect of vitamins, sequela
|
T45.3X5A
|
Adverse effect of enzymes, initial encounter
|
T45.3X5D
|
Adverse effect of enzymes, subsequent encounter
|
T45.3X5S
|
Adverse effect of enzymes, sequela
|
T45.4X5A
|
Adverse effect of iron and its compounds, initial encounter
|
T45.4X5D
|
Adverse effect of iron and its compounds, subsequent encounter
|
T45.4X5S
|
Adverse effect of iron and its compounds, sequela
|
T45.515A
|
Adverse effect of anticoagulants, initial encounter
|
T45.515D
|
Adverse effect of anticoagulants, subsequent encounter
|
T45.515S
|
Adverse effect of anticoagulants, sequela
|
T45.525A
|
Adverse effect of antithrombotic drugs, initial encounter
|
T45.525D
|
Adverse effect of antithrombotic drugs, subsequent encounter
|
T45.525S
|
Adverse effect of antithrombotic drugs, sequela
|
T45.615A
|
Adverse effect of thrombolytic drugs, initial encounter
|
T45.615D
|
Adverse effect of thrombolytic drugs, subsequent encounter
|
T45.615S
|
Adverse effect of thrombolytic drugs, sequela
|
T45.625A
|
Adverse effect of hemostatic drug, initial encounter
|
T45.625D
|
Adverse effect of hemostatic drug, subsequent encounter
|
T45.625S
|
Adverse effect of hemostatic drug, sequela
|
T45.695A
|
Adverse effect of other fibrinolysis-affecting drugs, initial encounter
|
T45.695D
|
Adverse effect of other fibrinolysis-affecting drugs, subsequent encounter
|
T45.695S
|
Adverse effect of other fibrinolysis-affecting drugs, sequela
|
T45.7X5A
|
Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, initial encounter
|
T45.7X5D
|
Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, subsequent encounter
|
T45.7X5S
|
Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, sequela
|
T45.8X5A
|
Adverse effect of other primarily systemic and hematological agents, initial encounter
|
T45.8X5D
|
Adverse effect of other primarily systemic and hematological agents, subsequent encounter
|
T45.8X5S
|
Adverse effect of other primarily systemic and hematological agents, sequela
|
T46.0X5A
|
Adverse effect of cardiac-stimulant glycosides and drugs of similar action, initial encounter
|
T46.0X5D
|
Adverse effect of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter
|
T46.0X5S
|
Adverse effect of cardiac-stimulant glycosides and drugs of similar action, sequela
|
T46.1X5A
|
Adverse effect of calcium-channel blockers, initial encounter
|
T46.1X5D
|
Adverse effect of calcium-channel blockers, subsequent encounter
|
T46.1X5S
|
Adverse effect of calcium-channel blockers, sequela
|
T46.2X5A
|
Adverse effect of other antidysrhythmic drugs, initial encounter
|
T46.2X5D
|
Adverse effect of other antidysrhythmic drugs, subsequent encounter
|
T46.2X5S
|
Adverse effect of other antidysrhythmic drugs, sequela
|
T46.3X5A
|
Adverse effect of coronary vasodilators, initial encounter
|
T46.3X5D
|
Adverse effect of coronary vasodilators, subsequent encounter
|
T46.3X5S
|
Adverse effect of coronary vasodilators, sequela
|
T46.4X5A
|
Adverse effect of angiotensin-converting-enzyme inhibitors, initial encounter
|
T46.4X5D
|
Adverse effect of angiotensin-converting-enzyme inhibitors, subsequent encounter
|
T46.4X5S
|
Adverse effect of angiotensin-converting-enzyme inhibitors, sequela
|
T46.5X5A
|
Adverse effect of other antihypertensive drugs, initial encounter
|
T46.5X5D
|
Adverse effect of other antihypertensive drugs, subsequent encounter
|
T46.5X5S
|
Adverse effect of other antihypertensive drugs, sequela
|
T46.6X5A
|
Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter
|
T46.6X5D
|
Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounter
|
T46.6X5S
|
Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, sequela
|
T46.7X5A
|
Adverse effect of peripheral vasodilators, initial encounter
|
T46.7X5D
|
Adverse effect of peripheral vasodilators, subsequent encounter
|
T46.7X5S
|
Adverse effect of peripheral vasodilators, sequela
|
T46.8X5A
|
Adverse effect of antivaricose drugs, including sclerosing agents, initial encounter
|
T46.8X5D
|
Adverse effect of antivaricose drugs, including sclerosing agents, subsequent encounter
|
T46.8X5S
|
Adverse effect of antivaricose drugs, including sclerosing agents, sequela
|
T46.995A
|
Adverse effect of other agents primarily affecting the cardiovascular system, initial encounter
|
T46.995D
|
Adverse effect of other agents primarily affecting the cardiovascular system, subsequent encounter
|
T46.995S
|
Adverse effect of other agents primarily affecting the cardiovascular system, sequela
|
T47.0X5A
|
Adverse effect of histamine H2-receptor blockers, initial encounter
|
T47.0X5D
|
Adverse effect of histamine H2-receptor blockers, subsequent encounter
|
T47.0X5S
|
Adverse effect of histamine H2-receptor blockers, sequela
|
T47.1X5A
|
Adverse effect of other antacids and anti-gastric-secretion drugs, initial encounter
|
T47.1X5D
|
Adverse effect of other antacids and anti-gastric-secretion drugs, subsequent encounter
|
T47.1X5S
|
Adverse effect of other antacids and anti-gastric-secretion drugs, sequela
|
T47.2X5A
|
Adverse effect of stimulant laxatives, initial encounter
|
T47.2X5D
|
Adverse effect of stimulant laxatives, subsequent encounter
|
T47.2X5S
|
Adverse effect of stimulant laxatives, sequela
|
T47.3X5A
|
Adverse effect of saline and osmotic laxatives, initial encounter
|
T47.3X5D
|
Adverse effect of saline and osmotic laxatives, subsequent encounter
|
T47.3X5S
|
Adverse effect of saline and osmotic laxatives, sequela
|
T47.4X5A
|
Adverse effect of other laxatives, initial encounter
|
T47.4X5D
|
Adverse effect of other laxatives, subsequent encounter
|
T47.4X5S
|
Adverse effect of other laxatives, sequela
|
T47.5X5A
|
Adverse effect of digestants, initial encounter
|
T47.5X5D
|
Adverse effect of digestants, subsequent encounter
|
T47.5X5S
|
Adverse effect of digestants, sequela
|
T47.6X5A
|
Adverse effect of antidiarrheal drugs, initial encounter
|
T47.6X5D
|
Adverse effect of antidiarrheal drugs, subsequent encounter
|
T47.6X5S
|
Adverse effect of antidiarrheal drugs, sequela
|
T47.7X5A
|
Adverse effect of emetics, initial encounter
|
T47.7X5D
|
Adverse effect of emetics, subsequent encounter
|
T47.7X5S
|
Adverse effect of emetics, sequela
|
T47.8X5A
|
Adverse effect of other agents primarily affecting gastrointestinal system, initial encounter
|
T47.8X5D
|
Adverse effect of other agents primarily affecting gastrointestinal system, subsequent encounter
|
T47.8X5S
|
Adverse effect of other agents primarily affecting gastrointestinal system, sequela
|
T48.0X5A
|
Adverse effect of oxytocic drugs, initial encounter
|
T48.0X5D
|
Adverse effect of oxytocic drugs, subsequent encounter
|
T48.0X5S
|
Adverse effect of oxytocic drugs, sequela
|
T48.1X5A
|
Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter
|
T48.1X5D
|
Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], subsequent encounter
|
T48.1X5S
|
Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], sequela
|
T48.295A
|
Adverse effect of other drugs acting on muscles, initial encounter
|
T48.295D
|
Adverse effect of other drugs acting on muscles, subsequent encounter
|
T48.295S
|
Adverse effect of other drugs acting on muscles, sequela
|
T48.3X5A
|
Adverse effect of antitussives, initial encounter
|
T48.3X5D
|
Adverse effect of antitussives, subsequent encounter
|
T48.3X5S
|
Adverse effect of antitussives, sequela
|
T48.4X5A
|
Adverse effect of expectorants, initial encounter
|
T48.4X5D
|
Adverse effect of expectorants, subsequent encounter
|
T48.4X5S
|
Adverse effect of expectorants, sequela
|
T48.5X5A
|
Adverse effect of other anti-common-cold drugs, initial encounter
|
T48.5X5D
|
Adverse effect of other anti-common-cold drugs, subsequent encounter
|
T48.5X5S
|
Adverse effect of other anti-common-cold drugs, sequela
|
T48.6X5A
|
Adverse effect of antiasthmatics, initial encounter
|
T48.6X5D
|
Adverse effect of antiasthmatics, subsequent encounter
|
T48.6X5S
|
Adverse effect of antiasthmatics, sequela
|
T48.995A
|
Adverse effect of other agents primarily acting on the respiratory system, initial encounter
|
T48.995D
|
Adverse effect of other agents primarily acting on the respiratory system, subsequent encounter
|
T48.995S
|
Adverse effect of other agents primarily acting on the respiratory system, sequela
|
T49.0X5A
|
Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, initial encounter
|
T49.0X5D
|
Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, subsequent encounter
|
T49.0X5S
|
Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, sequela
|
T49.1X5A
|
Adverse effect of antipruritics, initial encounter
|
T49.1X5D
|
Adverse effect of antipruritics, subsequent encounter
|
T49.1X5S
|
Adverse effect of antipruritics, sequela
|
T50.0X5A
|
Adverse effect of mineralocorticoids and their antagonists, initial encounter
|
T50.0X5D
|
Adverse effect of mineralocorticoids and their antagonists, subsequent encounter
|
T50.0X5S
|
Adverse effect of mineralocorticoids and their antagonists, sequela
|
T50.1X5A
|
Adverse effect of loop [high-ceiling] diuretics, initial encounter
|
T50.1X5D
|
Adverse effect of loop [high-ceiling] diuretics, subsequent encounter
|
T50.1X5S
|
Adverse effect of loop [high-ceiling] diuretics, sequela
|
T50.2X5A
|
Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounter
|
T50.2X5D
|
Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, subsequent encounter
|
T50.2X5S
|
Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, sequela
|
T50.3X5A
|
Adverse effect of electrolytic, caloric and water-balance agents, initial encounter
|
T50.3X5D
|
Adverse effect of electrolytic, caloric and water-balance agents, subsequent encounter
|
T50.3X5S
|
Adverse effect of electrolytic, caloric and water-balance agents, sequela
|
T50.4X5A
|
Adverse effect of drugs affecting uric acid metabolism, initial encounter
|
T50.4X5D
|
Adverse effect of drugs affecting uric acid metabolism, subsequent encounter
|
T50.4X5S
|
Adverse effect of drugs affecting uric acid metabolism, sequela
|
T50.5X5A
|
Adverse effect of appetite depressants, initial encounter
|
T50.5X5D
|
Adverse effect of appetite depressants, subsequent encounter
|
T50.5X5S
|
Adverse effect of appetite depressants, sequela
|
T50.6X5A
|
Adverse effect of antidotes and chelating agents, initial encounter
|
T50.6X5D
|
Adverse effect of antidotes and chelating agents, subsequent encounter
|
T50.6X5S
|
Adverse effect of antidotes and chelating agents, sequela
|
T50.7X5A
|
Adverse effect of analeptics and opioid receptor antagonists, initial encounter
|
T50.7X5D
|
Adverse effect of analeptics and opioid receptor antagonists, subsequent encounter
|
T50.7X5S
|
Adverse effect of analeptics and opioid receptor antagonists, sequela
|
T50.8X5A
|
Adverse effect of diagnostic agents, initial encounter
|
T50.8X5D
|
Adverse effect of diagnostic agents, subsequent encounter
|
T50.8X5S
|
Adverse effect of diagnostic agents, sequela
|
T79.4XXA
|
Traumatic shock, initial encounter
|
T79.4XXD
|
Traumatic shock, subsequent encounter
|
T79.4XXS
|
Traumatic shock, sequela
|
T81.12XA
|
Postprocedural septic shock, initial encounter
|
T81.12XD
|
Postprocedural septic shock, subsequent encounter
|
T81.12XS
|
Postprocedural septic shock, sequela
|
T86.11
|
Kidney transplant rejection
|
T86.12
|
Kidney transplant failure
|
T86.13
|
Kidney transplant infection
|
T86.19
|
Other complication of kidney transplant
|
Z48.21
|
Encounter for aftercare following heart transplant
|
Z48.22
|
Encounter for aftercare following kidney transplant
|
Z48.23
|
Encounter for aftercare following liver transplant
|
Z48.280
|
Encounter for aftercare following heart-lung transplant
|
Z49.31
|
Encounter for adequacy testing for hemodialysis
|
Z49.32
|
Encounter for adequacy testing for peritoneal dialysis
|
Z51.11
|
Encounter for antineoplastic chemotherapy
|
Z51.12
|
Encounter for antineoplastic immunotherapy
|
Z79.2
|
Long term (current) use of antibiotics
|
Z79.4
|
Long term (current) use of insulin
|
Z79.51
|
Long term (current) use of inhaled steroids
|
Z79.52
|
Long term (current) use of systemic steroids
|
Z79.83
|
Long term (current) use of bisphosphonates
|
Z79.84
|
Long term (current) use of oral hypoglycemic drugs
|
Z79.891
|
Long term (current) use of opiate analgesic
|
Z79.899
|
Other long term (current) drug therapy
|
Z92.21
|
Personal history of antineoplastic chemotherapy
|
Z92.22
|
Personal history of monoclonal drug therapy
|
Z92.26
|
Personal history of immune checkpoint inhibitor therapy
|
Z94.0
|
Kidney transplant status
|
Z94.1
|
Heart transplant status
|
Z94.3
|
Heart and lungs transplant status
|
Z94.4
|
Liver transplant status
|
Z94.83
|
Pancreas transplant status
|